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Chemiluminescence is the light emission from a chemical reaction. The excited state is 
accessed in the course of a chemical reaction and relaxes to the ground state with the emission of 
a photon. Independence from the need for light excitation gives chemiluminescence several 
advantages over fluorescence including better signal-to-noise ratio and reduced background at 
deeper tissue imaging depth. As a result, the sensitivity of chemiluminescent probes for biological 
analyte detection has been improved significantly. Because of the sensitivity of chemiluminescent 
probes, we are planning to use this technique to quantify important factors for biological activities. 
In this dissertation, two quantification methods to study biological activities will be 
introduced in detail. The first one is a pH quantification system based on a pH sensitive 
chemiluminescent system. In aqueous solution, the light emission from the chemiluminescent 
probe will transfer to a ratiometric pH sensitive dye caboxy-SNARF-1 in the presence of a 
commercially available enhancer. By plotting out the light emission ratio of the dual emission 
peaks of carboxy-SNARF-1 with various pH, we can use this system as an optical pH detection 
method.  
The second project in this dissertation is the development of a chemiluminescent HNO 
probe. Pharmacological HNO is related to a wide range of biological activities, but its detection is 
difficult because of its instability and activity towards biological molecules. Based on a 1,2-
spirodioxetane structure, with the acrylonitrile on the orthro position of the phenolate, we 
synthesized the first HNO chemiluminescent probe, HNOCL-1. The chemiluminescent intensity 
of the scaffold has been improved significantly and is capable of HNO detection in the nanomolar 
scale. With HNOCL-1, we successfully detected and quantified the HNO generated from the 
reaction between NO and H2S, which is one of the possible endogenous sources of HNO. 
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Chapter 1 Introduction to Chemiluminescence 
1.1 Chemiluminescence  
 
Scheme 1 - 1. Jablonski Diagram for Chemiluminescence Mechanism. 
From the fireflies in the woods, luminescent bacteria in the lakes, and jellyfish deep under 
the sea, the splendid light emission of light is a beautiful part of the natural world. Back to the city, 
people use glow sticks for parties, concerts and celebrations for festivals. Detectives and police 
used luminol to track the hint of wiped blood. This chemical based light emission, which is called 
chemiluminescence, is almost everywhere is people’s life. It is the remarkable production of light 
from exothermic chemical reactions that can be understood using a Jablonski diagram describing 












excited state S1 upon obtaining a sufficient amount of energy, which could come from the light 
absorbance or a chemical reaction. For chemiluminescence, the energy is obtained from the 
chemical reaction. Internal conversion happens when the electron relaxes to a lower energy state 
without photon emission. The relaxation of the electron to the ground state with the release of a 
photon will cause the light emission (Scheme 1-1). For fluorescence, the energy to excite the 
electron is from external light. Intersystem crossing can also happen in this process, which is the 
electron transition to the triplet excited state T1 before relaxation to the ground state with a slower 
transition rate in a process called phosphorescence.1 Compared with fluorescence, light emission 
from chemiluminescence does not rely on external light sources, which significantly increases the 
tissue depth that can be adequately imaged when applied in a biological system. Meanwhile, 
chemiluminescence will give a lower background in biological system due to reduced 
autofluorescence and light scattering. Hence chemiluminescence is very useful for analytical 
chemistry and has been used in a wide range of applications. 
The application of chemiluminescence as an analytical method has been studied for a long 
time since the concentration for most endogenous compounds have a low concentration and are 
hard to detect.1 Before chemiluminescence methods, radiolabeling detection was a leading way to 
trace analytes in biological systems, but has several drawbacks.2 Chemiluminescence provides a 
less complicated and cheaper way compared to radiolabeling procedures. Studies on luminol,4 
acridinium,5-6 peroxyoxalate,7 luciferin and luciferase8 and sterically stabilized 1,2-dioxetanes1 are 
the most commonly reported systems.  
 
1.2 Introduction of chemiluminescent systems 
1.2.1 Luminol and its derivatives 
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The principle of light emission is the oxidation of the heterocyclic ring by a series of 
oxidants to yield an important intermediate α-hydroxyperoxide, which decomposes to yield the 
excited aminophthalate ion which relaxes back to the ground state and emits light.4 The oxidization 
of luminol in protic solution needs oxidants that can include molecular oxygen, peroxides or 
superoxide anion, but this reaction requires the presence of catalysis such as enzyme and medals 
complexes.5  
 
1.2.2 Acridinium and its derivatives 
 
Scheme 1 - 3. Chemiluminescence of acridinium. 
The basic chemiluminescence mechanism for acridinium and its derivatives is shown in 
Scheme 1-3. With the hydroperoxide and a strong base, the acridinium will decompose and release 
the acridone in its excited state, which will release a bright blue emission when it relaxes to the 
ground state.6-7 It has been used as a efficient tool to label DNA strands without reacting with 






























1.2.3 Peroxyoxalate and its derivatives 
 
Scheme 1 - 4. Chemiluminescence of peroxyoxalic ester. 
Peroxyoxalate and its derivatives have an aryl oxalate ester structure, which can react with 
hydrogen peroxide to form the dioxetanedione with high energy. The dioxetanedione can 
chemically excite the fluorophore to the S1 state and trigger the luminescence process.8 However, 
the low stability and solubility in water limit the application of peroxyoxalic compounds in 
biological systems.9 
1.2.4 Luciferin and luciferase 
 
Scheme 1 - 5. Chemiluminescence of luciferin with luciferase. 
The basic light emission mechanism for luciferin and luciferase chemiluminescent system 
is shown in Scheme 1-5. In the presence of ATP, O2 and Mg2+, luciferin will be catalyzed by 
luciferase and turn into an intermediate with the 1,2-dioxetane, which will decompose into the 
oxyluciferin in its excited state and release visible light when it relaxes into ground state.10 The 
luciferase and luciferin bioluminescent system has a broad range of application. With various 















































series of biological activities including viral infection, host response, antiviral therapy and real 
time monitoring and quantification of small molecule analytes.11 
1.2.5 1,2-dioxetane 
 
Scheme 1 - 6. Chemiluminescence of 1,2-dioxetane. 
The chemiluminescence mechanism of 1,2-dioxetane is shown is Scheme 1-6. There are 
two distinct pathways for its decomposition, thermal and chemical decomposition. The thermal 
decomposition of the 1,2-dioxetane will lead to the formation of the diradical intermediate and 
release the decomposition product ketone in its triplet state (T1), which will be rapidly quenched 
in aqueous solution. The chemical decomposition pathway will go through the chemically initiated 
electron exchange luminescence (CIEEL) process, and lead to the generation of a ketone in its 
singlet state (S1), which will emit light upon relaxing to the ground state. The generation of the 
singlet intermediate makes the chemical decomposition for 1,2-dioxetane more efficient in 














1.3 Development and Application of 1,2-spirodioxetane 
1.3.1 Development of 1,2-spirodioxetane 
 
Scheme 1 - 7. Development of 1,2-dioxetane as a chemiluminescent probe. 
Hundreds of molecules have been synthesized based on the 1,2-dioxetane structure.1 When 
the 1,2-dioxetane moiety was first synthesized in 1969 (Scheme 1-7), it had several drawbacks 
including thermal instability and aqueous quenching.1 In 1972, more stable structures of 1,2-
dioxetane with a 1,1′-biadamantyl group as stabilizer were developed, which have a higher 
decomposition temperature and a longer half-life.12 The asymmetric structure of 1,2-dioxetane was 
synthesized later. The chemiluminescence process would be triggered once the analyte-responsive 
protecting group is removed.13-14 Schaap and his group developed several structures with a 
silylated or ester group as protecting groups, which could react with fluoride anions or arylesterase 
and initiate chemiluminescent processes in organic solvents (Scheme 1-7).15-17 Later, Bronstein 
and colleagues developed (3-(2,7-spiroadamantane)-4-methoxy-4-(3-phosphoryloxy)phenyl-1,2-
dioxetane disodium salt also named 3-4-methoxyspiro(1,2-dioxetane-3,27-tricyclo[3.3.1.1.3,7]-
decan)-4-yl phenylphosphate disodium salt (AMPPD), the solubility in water and comparatively 
stability at room temperature make it one of the most common structure for chemiluminescent 
probes.13 Recently Shabat’s group develop several powerful chemiluminescent probes. By 
attaching the acrylate or acrylonitrile electron-withdrawing group to the benzyl moiety, the 
quantum yield and chemiluminescent intensity are increased dramatically.18 
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1.3.2 Chemically initiated electron exchange luminescence 
 
Scheme 1 - 8. Chemical initiated electron exchange luminescence.16 
CIEEL is light emission from electron-transfer chemistry, which is part of the 
chemiluminescent process. Intermolecular electron transfer or intramolecular electron transfer of 
thermostabilized spiroadamantyl-substituted dioxetanes is the main reason for CIEEL. When the 
protecting group is removed from the scaffold, it will release the phenolate anion, which would 
lead to the decomposition of spiroadamantyl-substituted dioxetane and initiate the light emission. 
Two alternative decomposition mechanisms have been proposed for CIEEL process. The cleavage 
of the phenolate anion will lead to the intramolecular electron transfer (ET) from the phenolate 
moiety to the antibonding s* orbital with the cleavage of O-O bond.19 This is the rate-limiting step 
for CIEEL since it need energy for the electron transfer from the phenolate to the peroxide bond. 
The excited methyl m-oxybenzoate ion could be formed from the direct electron transfer, but the 
research evidence support the alternative way, which is the electron back transfer (BET). BET 
happens in the slovent cage between the radical fragments from the decomposition of 
spiroadamantyl-substituted dioxetanes phenolate, which has been demonstrated by the solvent 
viscosity dependence of the chemiexcitation yield of the system. This phenomenon has been 
demonstrated that the chemiexcitation yield is rising with the increasing viscosity.20 Finally, the 






























1.3.3 Probes based on 1,2-spirodioxetane in aqueous solution 
 
Scheme 1 - 9. Probes based on 1,2-spirodioxetane scaffold. 
A range of probes based on the 1,2-spirodioxetane scaffold for reactive oxygen and 
nitrogen species and reactive biological analyte detection has been synthesized recently in our lab 
(Scheme 1-9). CHS-1-3 are the first generation of these probes. The benzyl azide will react with 
H2S and yield an aniline, which will lead to the generation of the phenolate ion and CIEEL. 
Although among these probes, CHS-3 gives the strongest light emission, it still relies on the 
addition of a commercially available enhancer, Emerald II to increase light emission.21 Later, the 
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chlorinated 1,2-dioxetane Hycl-2 was synthesized as a tool to detect hypoxia. The nitrobenzene 
will be reduced to aniline under hypoxic conditions by mammalian reductive enzymes and release 
the phenolate ion to initiate the CIEEL process. This scaffold still relies on the addition of 
enhancers to magnify the emission intensity.22 A pH quantification system with the addition of the 
enhancer was developed later after Hycl-2.23 With the attachment of an acrylate or acrylonitrile 
electron-withdrawing group to the aromatic moiety, the chemiluminescence emission intensity of 
the 1,2-spirodioxetane has been significantly improved because the quantum yield of the 
fluorophore released from the decomposition of the dioxetane has increased.18 As a result, probes 
based on the acrylate and acrylonitrile dioxetane do not require the addition of enhancers for 
reactive oxygen and nitrogen species detection. PNCL and HNOCL-1 were synthesized later to 
detect ONOO– and HNO respectively and gave a high sensitivity towards the analytes.24-25 
Recently, our group found with the addition of the acetoxymethyl ester to the benzoic moiety could 
increase the cell trappability of the 1,2-dioxetane. Upon reaction with intercellular esterases when 
treating the cells with the probe, the acrylate carboxylic acid intermediate will be released from 
the system and increase the solubility of the scaffold. As a result, light emission will be improved 
significantly. Based on this structure, our group developed the second-generation probes for 
hypoxia detection Hycl-3 and Hycl-4-AM that gave us a much brighter response towards hypoxia 
upon adding to the cells compared with other probes.26 
 
1.4 Research objectives 
This dissertation aims to quantify factors that are related to certain biological activities. The aim 
for the pH quantification project is using a chemiluminescent probe as the light source to transfer 
light emission to a ratiometric pH sensitive fluorophore carboxy-SNARF-1. By establishing a 
standard graph of the relationship between pH and light emission ratio, it can be used to detect the 
pH using an optical method.27 The HNO quantification project aims to development a highly 
selective and sensitive chemiluminescent probe HNOCL-1 to detect HNO at nanomolar 
concentrations. The HNO detection and quantification has been successfully conducted in vitro to 
provide a quantification of HNO generated. Hence, HNOCL-1 could provide an efficient way to 
study the pathways and functions of HNO in biological systems in the future. 
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Chapter 2 Detection of pH with a chemiluminescent probe 
2.1 Introduction 
2.1.1 Misregulated pH in cancer cells 
 
Figure 2- 1. Misregulated pH in cancer and normal cells. 
 
Regulated pH is an important factor to keep the balance of the human body. Normal cells 
have a lower intracellular pH (pHi) of 7.2 compared to the extracellular pH (pHe) of 7.4, which is 
buffered by HCO3– (Figure 2-1).1 This characteristic is important for normal adult cell metabolism 
and apoptosis.2 Cancer cells have a higher intracellular pH and lower extracellular pH compared 
to normal adult cells. The increased production of lactic acid and the change of the expression of 
the cell membrane transporters and pumps lead to this abnormal pH condition of cancer cells.3 The 
fast proliferation rate of cancer cells means that the normal cellular metabolism in healthy adult 
cells cannot meet the requirement for energy.4 As a result, cancer cells resort to another way of 



























lactic acid.4 Meanwhile, a change in the expression of ion pumps and transporters on the cell 
membrane speeds up the H+ efflux and leads to the increase of extracellular H+ concentration.5 
 
2.1.2 High intracellular pH increases proliferation 
The higher intracellular pH (pHi > 7.2) is a key factor for cancer cell proliferation due to 
the inhibition of cell acidification controlled apoptosis.6 The function of cyclin-dependent kinase 
1 (CDK1), the key complex for promoting mitosis, is limited under lower pHi.7 However, a higher 
intracellular pH facilitates the CDK1 activities and promotes G2/M process entry and cell mitosis.7 
Also, pH dynamics can change the activity of certain proteins and inhibit several processes of cell 
apoptosis.8 In acidic cytosol, a pre-apoptosis protein induces pore formation on the mitochondria 
membrane and releases another pre-apoptosis protein cytochrome c, which is important to facilitate 
the activity of caspases and at pH 6.8, efficiency of these caspases reaches maximum.8 With a 
higher pHi the function of cytochrome c will be suppressed and the cell death process will be 
inhibited.9 Moreover, the function of lactate dehydrogenase, a key enzyme for pyruvate conversion 
of lactate, is maximal at pH 7.5. Furthermore, the activity of the most important glycolysis rate 
regulated enzyme phosphofructokinase 1 is increased with an alkaline pH shift.10 
 
2.1.3 Low extracellular pH increases invasion and metastasis 
Meanwhile, a lower pHe is the main reason for extracellular matrix (ECM) remodeling and 
acid-activated protease activities enhance and promote tumor cell invasion and metastasis.11 An 
ECM degradation enzyme, matrix metalloproteinase 3 is more active at lower pHe.12 However, the 
reason for the dysfunction is not well understood. Hence, it’s important to monitor the real time 




2.1.4 pH measurement by magnetic resonance 
Magnetic resonance is a key technique for measuring pH in tumors and measurement 
methods include 31P MRS,13 19F MRS,14 13C MRS,15 magnetization transfer16 and pH-dependent 
chemical reagents.17 Some of these methods are aimed at testing the endogenous resonance while 
other require exogenous reagent injection.  31P MRS is used to detect the resonance of endogenous 
phosphate Pi, but for necrosis cells, the extracellular Pi is also visible on the spectra, which can 
cause the appearance of complicated resonances. Another method is to measure the extracellular 
pH by injecting 3-aminopropylphosphate (3-APP), which is membrane impermeable and non-
toxic, and measures the pH-dependent shift of 31P.15 Another pH measurement by MRS is 19F MRS, 
which has a high gyromagnetic ratio and is not be influenced by endogenous sources of 19F, which 
are very low in tissue. By injecting exogenous reagents, it is possible to obtain the spectra with 
large chemical shift dispersion. 1H MRS can also provide highly sensitive spectra with a stable, 
downfield region with slight interferences.18 Even though some endogenous molecules can also 
have H-resonance responses, these compounds are too dilute to be observed from the spectra. 
Hyperpolarized 13C MRS is also an innovative method to detect the intercellular pH by intravenous 
injection of hyperpolarized bicarbonate H13CO3–.17 
 
2.1.5 Ratiometric pH sensitive fluorescent probe: carboxy-SNARF-1 
 






















Numerous pH sensitive fluorescent probes have been synthesized and reviewed.19-20 The 
light emission of these probes will shift with the change of pH. It is because of protonation or 
deprotonation of a certain function group.19-20 Carboxy-SNARF-1 is a commonly used ratiometric 
dye that has a clear isosbestic point at around 600 nm. Its pKa is around 7.4, which is appropriate 
as a pH detector. The single excitation and dual emission of carboxy-SNARF-1 make it a 
convenient dye for pH detection in various instruments.21,23 
2.1.6 pH measurement by optical methods 
Optical pH measurement is another commonly used strategy to detect pH. With the 
existence of a ratiometric pH sensitive fluorescent dye – carboxy-SNARF-1 and cell membrane 
permeable fluorescein, the pH of mitochondria has been detected by high resolution confocal 
scanning laser microscopy (CSLM) and multiphoton laser scanning microscopy (MPLSM).22 
CSLM is able to detect emission signals at different wavelengths at the same time. This property 
enables the detection of the two emission peaks of carboxy-SNARF-1 in various pH 
microenvironments.23 Another pH detection method is using pH (Low) Insertion peptide–pHLIP.24 
The peptide is a water-soluble polypeptide and would form a transmembrane alpha helix with the 
drop of intercellular pH from 7.4 to around 6.5–7.0. By this way, cargo molecules can attach to 




The CIEEL is generated with the decomposition of the deprotonated 1,2-spirodioxetane 
phenolate ion. The decomposition rate of phenolate ion is 4.4 x 106 faster than the protonated 
phenol.25 The fluorophore released from decomposition of the probe is in a charge transfer state, 
which can be quenched by proton transfer in the protic solution. Fortunately, the quenching process 
can be prevented by the hydrophobic microenvironment formed by the surfactant from the 
enhancer. With the addition of the enhancer, the chemiluminescence emission intensity will be 
improved significantly.26 Meanwhile, the micelle formed from the added surfactant would attach 
the fluorophores to the system and increase the energy transfer efficiency.27 In our lab, we used 
the commercially available enhancers Emerald II and Sapphire II to improve the chemiluminescent 
emission intensity. There is also a fluorophore in the enhancers that can be excited by the CIEEL 
and lead to the red-shift of the emission. Poly (vinylbenzyltrimethylammoniumchloride) (TMQ), 
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poly (vinylbenzyltributylammoniumchloride) (TBQ) and poly 
(vinylbenzyldimethylbenzylammonium chloride) (BDMQ) are the surfactants include in the 
enhancers. By surrounding the 1,2-dioxatane structure into the hydrophobic microenvironment, 
they keep the protonation of the 1,2-dioxetane and enhance the chemiluminescence of the probe. 
2.2 Results and discussion 
2.2.1 Design and synthesis of pH sensitive probe and ratiometric pH sensitive fluorophore 
 
Scheme 2 - 2. Synthesis procedures of 1. 
The synthesis procedure of the 1,2-dioxetane probe is adopted from previous work in our 
laboratory.28 First, we treated the 4-chloro-3-methoxylbenzaldehyde 2 with trimethyl orthoformate 
in MeOH in the presence of p-toluenesulfonic acid to yield acetal 3. The acetal 3 was treated with 
triethyl phosphite and boron trifluoride diethyl etherate to obtain the diethyl methoxy (3-
methoxyphenyl) methyl phosphonate 4. We ran the Horner–Wadsworth–Emmons reaction with 
the phosphonate 4, n-BuLi and 2-admantanone to yield the enol ether 5. Next, the enol ether 5 
would go through a demethylation reaction upon treatment with sodium ethanethiolate and cesium 
carbonate to obtain the phenol 6. Later, I protected the phenol with a MOM protecting group 
through the addition of chloromethoxymethane29 to yield the MOM protected enol ether 8. The 
MOM protected enol ether underwent reaction with Rose bengal as the catalyst and O2 bubbled 
through the system, and this procedure obtained the 1,2-dioxetane structure MOM protected 
product 8. The MOM protecting group was removed by adding p-toluenesulfonic acid to yield the 

























































2.2.2 Synthesis and isolation of carboxy-SNARF-1 
 
Scheme 2 - 3. Synthesis procedures of carboxy-SNARF-1. 
The synthesis of carboxyl-SNARF-1 was adapted from the procedure published by Dr. 
Christopher J. Chang in 2011.30 1,3-Dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid mixed 
with 3-dimethylaminophenol was heated up to 110°C and stirred overnight in toluene to yield the 
product 9. The product 9 was mixed with 1,6-naphthalenediol in pure MeSO3H and stirred for 1 
hour and obtain the product 10 as a purple solid.30  
 
2.2.3 Mechanisms of pH quantification 
 

































































Because of the low background and less light scattering chemiluminescence, our lab 
developed a pH quantification system based on a chemiluminescent scaffold with the addition of 
a ratiometric pH sensitive dye. Scheme 2-4 shows the mechanism of the system. Light emission 
from the chemiluminescent compound 1 in the Emerald II or Sapphire II enhancer solution will be 
transferred to a ratiometric pH sensitive fluorophore carboxy-SNARF-1. The light emission will 
alter from 585 nm in the protonated form at lower pH to 650 nm in the deprotonated form at higher 
pH. The ratio of the light emission from these two peaks will be a constant number at a given pH, 
which will enable the pH quantification in an aqueous solution.  
 
2.2.4 Chemiluminescence response towards pH in different enhancer 
 
Figure 2- 2. The pH dependent (A) emission spectrum and (B) ratio of the chemiluminescence 
emission intensities at 650 nm and 585 nm of 60 μM 1 and 80 μM carboxy-SNARF-1 in aqueous 
buffer (pH 5.99–10) containing 6% Sapphire II Enhancer. The pH dependent (C) emission 
spectrum and (D) ratio of the chemiluminescence emission intensities at 650 nm and 585 nm of 
60 μM 1 and 80 μM carboxy-SNARF-1 in aqueous buffer (pH 5.99–10) containing 6% Emerald 
II Enhancer. 
 
To obtain the pH sensitivity properties of 1 and the ratiometric pH sensitive dye carboxy-
SNARF-1, we first characterized the chemiluminescence result using a F-7000 Hitachi 
thesize and isolate the free phenol 1 (Scheme 2). Phenol 1 will
equilibrate with the phenolate form, which spontaneously
decomposes in a chemically initiated electr n exchange lum-
ninscence (CIEEL) mechanism to access the excited state and
emit light. We hypothesized that protecting the phenol with a
methoxymethyl ether (MOM) protecting group would enable
acid-mediated deprotection after the [2 + 2] cycloaddition,
thereby avoiding exposure of the phenol to basic conditions
that are known to decompose this class of 1,2-dioxetanes.
Starting from the known enol ether 2,20 treatment with
MOMCl provided the protected enol ether 3, which was then
treated with singlet oxygen generated using Rose bengal to
mediate the conversion of triplet oxygen to singlet oxygen and
yield 4. The MOM-protected dioxetane was then deprotected
with para-toluenesulphonic acid (p-TSA) in methanol to
provide the free phenol 1, which was purified by silica column
chromatography. Carboxy-SNARF-1 was prepared by adapting a
literature procedure.41
With 1 and carboxy-SNARF-1 in hand, we proceeded to
characterize the chemiluminescence emission of this com-
bined system with an aim to determining the possibility of
energy transfer to the ratiometric carboxy-SNARF-1. We pre-
pared aqueous solutions of 1 and carboxy-SNARF-1 buffered to
pH values between 6 and 10. In order to increase the magni-
tude of chemiluminescence emission, we added either
Emerald II Enhancer or Sapphire II Enhancer. These proprie-
tary solutions consist of a tetra-alkyl ammonium polymer that
co-encapsulates the dioxetane and a fluorescent dye to
enhance chemiluminescence emission and red-shift the emis-
sion wavelength via energy transfer. Measurements with a pH
meter confirmed that there was no significant change in the
pH in buffered solutions containing 6% Enhancer by volume.
Solutions of 1, carboxy-SNARF-1, and Sapphire II Enhancer dis-
played two peaks in the chemiluminescence emission spectra
at 467 nm and 650 nm (Fig. 1A), which can be assigned to the
phenolate derived from chemiluminescent decomposition of 1
(slightly red-shifted in the Sapphire II Enhancer solution) and
carboxy-SNARF-1, respectively. As the pH of the solution
increases, the intensity of each peak increases due to a larger
equilibrium concentration of the phenolate. This is in contra-
distinction to fluorescence imaging using carboxy-SNARF-1,
which is characterized by an isoemissive point.42 Careful
inspection of Fig. 1A, however, reveals that the carboxy-
SNARF-1 peak increases more rapidly with increasing pH due
to increased concentration of the deprotonated form, provid-
ing the wavelength-dependent emission that is needed for
ratiometric measurement. Indeed, by plotting the rati of the
chemiluminescence emission intensities of the protonated
and deprotonated forms of carboxy-SNARF-1 (585 nm and
650 nm, respectively), a ratiometric pH-dependent plot can be
constructed (Fig. 1B). This ratiometric response shows a 5.6-
fold increase from pH 5.99 to pH 10.02. A similar exp riment
was performed using Emerald II Enhancer that displayed three
peaks in the chemiluminescence emission spectra at 460 nm,
535 nm, and 650 nm (Fig. 1C), which can be assigned to the
phenolate derived from chemiluminescent decomposition of
1, Emerald II Enhancer, and carboxy-SNARF-1, respectively.
Scheme 1 Energy transfer chemiluminescence for ratiometric pH
imaging.
Scheme 2 Synthesis and isolation of phenol 1.
Fig. 1 The pH dependent (A) emission spectrum and (B) ratio of the
chemiluminescence e ission intensities at 650 nm and 585 nm of
60 µM 1 and 80 µM carboxy-SNARF-1 in aqueous buffer (pH 5.99–10)
containing 6% Sapphire II Enhancer. The pH dependent (C) emission
spectrum and (D) ratio of the chemiluminescence emission intensities at
650 nm and 585 nm of 60 µM 1 and 80 µM carboxy-SNARF-1 in
aqueous buffer (pH 5.99–10) containing 6% Emerald II Enhancer.
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fluorometer. Luminescence response toward the change of pH was tested in PBS (0.02 M, pH 6.0–
8.0) buffer and sodium bicarbonate (0.01 M, pH 9.2–10.8) buffer solution. We developed the 
system with two different commercially available enhancers Emerald II and Sapphire II. With a 
tetra-alkyl ammonium polymer in the Sapphire II (6%) that encapsulates the dioxetane 1 and the 
carboxy-SNARF-1, the energy transfer efficiency has been significantly improved. There are two 
main emission peaks in the Sapphire II enhancer solution. The one at 467 nm is the light emission 
from the decomposition of 1 and the rising peak at 650 nm with the increasing pH is from the 
deprotonated carboxy-SNARF-1. We plotted out the ratio of light emission respectively at 650 
nm and 585 nm, which are the two emission peaks for protonated and deprotonated carboxy-
SNARF-1, and a pH dependent graph was constructed. The emission peak at 585 nm is masked 
by the peak at 467 nm, but this is still the peak at which the maximum change is observed. From 
this graph, we can see a 5.6-fold increase in the ratio with increasing pH from 5.99 to 10.02 (Figure 
2-2, A-B), which confirms that the system we have established has the ability to quantify the pH 
in an aqueous system. We observed similar results with another commercially available enhancer 
Emerald II. In the 6% Emerald II buffer solution, there are 3 emission peaks at 467 nm, 540 nm 
and 650 nm, which are respectively from the light emission of dioxetane 1, the fluorophore 
included in the enhancer and the deprotonated carboxy-SNARF-1. After plotting out the ratio of 
chemiluminescence at 650 nm and 585 nm, we can see a 5.7-fold increase in the ratio with the 
increasing pH from 5.99 to 10.02 in the graph (Figure 2-2, C-D).  
 
 44 
2.2.5 Evaluation of signal sensitivity to time and probe concentration 
 
Figure 2- 3. The independence of chemiluminescence emission on the concentration of 1. (A) 
Emission spectra at pH 7.42 and (B) ratio of the chemiluminescence emission intensity at 650 nm 
and 585 nm of 20–200 μM 1 and 80 μM carboxy-SNARF-1 in aqueous buffers (pH 5.99, 7.42, 
and 8.01) containing 6% Sapphire II Enhancer. (C) Emission spectra at pH 7.42 and (D) ratio of 
the chemiluminescence emission intensities at 650 nm and 585 nm of 20–200 μM 1 and 80 μM 
carboxy-SNARF-1 in aqueous buffers (pH 5.99, 7.42, and 8.01) containing 6% Emerald II 
Enhancer. 
 
After confirming the pH quantification ability of our probe, we proceeded to test the 
consistency of the ratiometric signal with other varying factors. The concentration of the dioxetane 
is one of the key factors that could change the light emission intensity from the system. The 
chemiluminescent emission becomes stronger with the increasing concentration of the dioxetane 
1. In the Sapphire II enhancer solution, we keep the concentration of carboxy-SNARF-1 and 
enhancer constant and vary the concentration of dioxetane 1 from 20 µM to 200 µM. After we plot 
out the ratio of chemiluminescence intensity from 650 nm to 585 nm, even though the light 
emission gets stronger with the rising concentration of dioxetane 1, the ratio does not change. 
Similar results were also found with the Emerald II enhancer solution. The ratio of emission at 650 
nm to 585 nm stays constant from 20 µM to 100 µM, and only a slight increase is observed from 
100 µM to 200 µM. 
 
Plotting the ratio of chemiluminscence emission at 650 nm
and 585 nm shows a 5.7-fold increase from pH 5.99 to pH
10.02 (Fig. 1D).
We next confirmed the consistency of the ratiometric signal
upon changing other variables. In previous work, we have
observed a kinetic decay of the chemiluminescent signal
in vivo,21 a factor that complicates precise quantification. In
this current system for chemiluminescent pH measurement, a
decay of the chemiluminescence emission intensity over time
is also observed in vitro using solutions of 1 and carboxy-
SNARF-1 in aqueous solutions buffered to pH 7.42 containing
6% Sapphire II Enhancer (Fig. 2A). While the overall intensity
decreases, analysis of the ratio of chemiluminescence emis-
sion at 650 nm and 585 nm reveals a steady signal over
30 minutes at pH 5.99, 7.42, and 8.01 (Fig. 2B). Similar results
are observed in analogous experiments using Emerald II
Enhancer (Fig. 2C and D). We also evaluated the consistency of
the ratiometric signal with respect to variable probe concen-
trations. It is often difficult to independently determine probe
localization in imaging experiments and increased localization
will lead to increased signal, potentially giving false positive
results. We evaluated this in vitro by increasing the concen-
tration of 1 when mixed with solutions of carboxy-SNARF-1
and Sapphire II Enhancer (Fig. 3A). Increased chemilumines-
cence emission intensity is observed with increased concen-
tration of the dioxetane 1. The intensity of each peak, however,
is incr ased propor ionally such that if the ratio of chemilumi-
nescence emission at 650 nm and 585 nm is plotted versus the
concentration of 1, a consistent signal is observed between
20 µM and 100 µM, with a slight upward trend at 200 µM
(Fig. 3B). Similar results are observed when using the Emerald
II Enhancer (Fig. 3C and D), but with less noise due to
increased chemiluminescence emission at 585 nm.
Next, the consistency of this ratiometric pH measurement
in different environmental conditions, including complicated
biological media was interrogated by comparing the ratio of
chemiluminescence emission at 650 nm and 585 nm with
different volumes of the Enhancer solutions and in the pres-
ence and absence of fetal bovine serum (Fig. 4). The ratio of
the chemiluminescence emission at 650 nm and 585 nm
(CL650/CL585) of solutions of 60 µM 1, 80 µM carboxy-SNARF-1,
and 6–14% Sapphire II Enhancer (Fig. 4A) or Emerald II
Enhancer (Fig. 4B) was measured. A slight reduction can be
seen when increasing the concentration of the Emerald II
Enhancer solution (Fig. 4B). This decrease in the ratiometric
chemiluminescent signal is smaller when using the Sapphire
II Enhancer solution (Fig. 4A). The attenuation of the ratio-
metric signal (CL650/CL585) is due to an increase in the emis-
sion at 585 nm from the shoulder of the Enhancer solution
emissions. This shoulder is more significant for the Emerald
II Enhancer solution because the Emerald II Enhancer has a
Fig. 2 Time dependent (A) emission spectrum at pH 7.42 and (B) ratio
of the chemiluminescence emission intensities at 650 nm and 585 nm
of 60 µM 1 and 80 µM carboxy-SNARF-1 in aqueous buffers (pH 5.99,
7.42, and 8.01) containing 6% Sapphire II Enhancer. Time dependent (C)
emission spectra at pH 7.42 and (D) ratio of the chemiluminescence
emission intensities at 650 nm and 585 nm and 60 µM 1 and 80 µM
carboxy-SNARF-1 in aqueous buffers (pH 5.99, 7.42, and 8.01) contain-
ing 6% Emerald II Enhancer.
Fig. 3 The dependence of chemiluminescence emission on the con-
centration of 1. (A) Emission spectra at pH 7.42 and (B) ratio of the
chemiluminescence emission intensity at 650 m and 585 nm of
20–200 µM 1 and 80 µM carboxy-SNARF-1 in aqueous buffers (pH 5.99,
7.42, and 8.01) containing 6% Sapphire II Enhancer. (C) Emission spectra
at pH 7.42 and (D) ratio of the chemiluminescence emission intensities
at 650 nm and 585 nm of 20–200 µM 1 and 80 µM carboxy-SNARF-1 in
aqueous buffers (pH 5.99, 7.42, and 8.01) containing 6% Emerald II
Enhancer.
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Figure 2- 4. Time independent (A) emission spectrum at pH 7.42 and (B) ratio of the 
chemiluminescence emission intensities at 650 nm and 585 nm of 60 μM 1 and 80 μM carboxy-
SNARF-1 in aqueous buffers (pH 5.99, 7.42, and 8.01) containing 6% Sapphire II Enhancer. Time 
dependent (C) emission spectra at pH 7.42 and (D) ratio of the chemiluminescence emission 
intensities at 650 nm and 585 nm and 60 μM 1 and 80 μM carboxy-SNARF-1 in aqueous buffers 
(pH 5.99, 7.42, and 8.01) containing 6% Emerald II Enhancer. 
 
Time is another important factor that could lead to the change of the chemiluminescent 
emission intensity since a decrease of chemiluminescent emission has been observed over time in 
solutions of dioxetane 1 in aqueous buffer solution with time scan mode. To test if time can cause 
any effect to the results, we did a wavelength scan of each sample every 5 mins for 30 mins. We 
plot out the result of the ratio of 650 nm emission to 585 nm. In the Sapphire II enhancer solution, 
we can see a significant decrease of chemiluminescent emission over time, but when we plot out 
the ratio, it stays constant. Similar results have been oberserved in an Emerald II enhacner solution. 
We also conducted this test with different pH buffers, and no matter how the time changes, the 
ratio stays the same. In this way, the time independence of this pH quantification system has been 
demonstrated. 
 
Plotting the ratio of chemiluminscence emission at 650 nm
and 585 nm shows a 5.7-fold increase from pH 5.99 to pH
10.02 (Fig. 1D).
We next confirmed the consistency of the ratiometric signal
upon changing other variables. In previous work, we have
observed a kinetic decay of the chemiluminescent signal
in vivo,21 a factor that complicates precise quantification. In
this current system for chemiluminescent pH measurement, a
decay of the chemiluminescence emission intensity over time
is also observed in vitro using solutions of 1 and carboxy-
SNARF-1 in aqueous solutions buffered to pH 7.42 containing
6% Sapphire II Enhancer (Fig. 2A). While the overall intensity
decreases, analysis of the ratio of chemiluminescence emis-
sion at 650 nm and 585 nm reveals a steady signal over
30 minutes at pH 5.99, 7.42, and 8.01 (Fig. 2B). Similar results
are observed in analogous experiments using Emerald II
Enhancer (Fig. 2C and D). We also evaluated the consistency of
the ratiometric signal with respect to variable probe concen-
trations. It is often difficult to independently determine probe
localization in imaging experiments and increased localization
will lead to increased signal, potentially giving false positive
results. We evaluated this in vitro by increasing the concen-
tration of 1 when mixed with solutions of carboxy-SNARF-1
and Sapphire II Enhancer (Fig. 3A). Increased chemilumines-
cence emission intensity is observed with increased concen-
tration of the dioxetane 1. The intensity of each peak, however,
is increased proportionally such that if the ratio of chemilumi-
nescence emission at 650 nm and 585 nm is plotted versus the
concentration of 1, a consistent signal is observed between
20 µM and 100 µM, with a slight upward trend at 200 µM
(Fig. 3B). Similar results are observed when using the Emerald
II Enhancer (Fig. 3C and D), but with less noise due to
increased chemiluminescence emission at 585 nm.
Next, the consistency of this ratiometric pH measurement
in different environmental conditions, including complicated
biological media was interrogated by comparing the ratio of
chemiluminescence emission at 650 nm and 585 nm with
different volumes of the Enhancer solutions and in the pres-
ence and absence of fetal bovine serum (Fig. 4). The ratio of
the chemiluminescence emission at 650 nm and 585 nm
(CL650/CL585) of solutions of 60 µM 1, 80 µM carboxy-SNARF-1,
and 6–14% Sapphire II Enhancer (Fig. 4A) or Emerald II
Enhancer (Fig. 4B) was measured. A slight reduction can be
seen when increasing the concentration of the Emerald II
Enhancer solution (Fig. 4B). This decrease in the ratiometric
chemiluminescent signal is smaller when using the Sapphire
II Enhancer solution (Fig. 4A). The attenuation of the ratio-
metric signal (CL650/CL585) is due to an increase in the emis-
sion at 585 nm from the shoulder of the Enhancer solution
emissions. This shoulder is more significant for the Emerald
II Enhancer solution because the Emerald II Enhancer has a
Fig. 2 Time dependent (A) emission spectrum at pH 7.42 and (B) ratio
of the chemiluminescence emission intensities at 650 nm and 585 nm
of 60 µM 1 and 80 µM carboxy-SNARF-1 in aqueous buffers (pH 5.99,
7.42, and 8.01) containing 6% Sapphire II Enhancer. Time dependent (C)
emission spectra at pH 7.42 and (D) ratio of the chemiluminescence
emission intensities at 650 nm and 585 nm and 60 µM 1 and 80 µM
carboxy-SNARF-1 in aqueous buffers (pH 5.99, 7.42, and 8.01) contain-
ing 6% Emerald II Enhancer.
Fig. 3 The dependence of chemiluminescence emission on the con-
centration of 1. (A) Emission spectra at pH 7.42 and (B) ratio of the
chemiluminescence emission intensity at 650 nm and 585 nm of
20–200 µM 1 and 80 µM carboxy-SNARF-1 in aqueous buffers (pH 5.99,
7.42, and 8.01) containing 6% Sapphire II Enhancer. (C) Emission spectra
at pH 7.42 and (D) ratio of the chemiluminescence emission intensities
at 650 nm and 585 nm of 20–200 µM 1 and 80 µM carboxy-SNARF-1 in
aqueous buffers (pH 5.99, 7.42, and 8.01) containing 6% Emerald II
Enhancer.
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2.2.6 In vitro testing in more complex systems 
 
Figure 2- 5. Ratiometric pH measurement in different environments. (A) Ratio of the 
chemiluminescence emission intensities at 650 nm and 585 nm of 60 μM 1 and 80 μM carboxy-
SNARF-1 in pH 7.42 buffers containing 6%–14% Sapphire II Enhancer. (B) Ratio of the 
chemiluminescence emission intensities at 650 nm and 585 nm of 60 μM 1 and 80 μM carboxy-
SNARF-1 in pH 7.42 buffers containing 6%–14% Emerald II Enhancer. (C) Ratio of the 
chemiluminescence emission intensity at 650 nm and 585 nm of 60 μM 1 and 80 μM carboxy-
SNARF-1 in 20 mM PBS buffered to pH 7.4 containing 6% Emerald II Enhancer in the absence 
and presence of 10% fetal bovine serum (FBS). 
 
The percentage of the enhancer also plays an important role in this system since it is a key 
factor for the energy transfer from the dioxetane 1 to carboxy-SNARF-1. As a result, it could 
potentially alter the ratio of CL650nm/CL585nm. The pH of the buffer would not change with varying 
percentage of the enhancer, which has been confirmed by pH meter. We observed a slight decrease 
of the CL650nm/CL585nm ratio with the increasing percentage of the Sapphire II enhancer. A similar 
result has been observed with Emerald II enhancer and the decrease in the ratio of CL650nm/CL585nm 
is a little bit more intense than the ratio of Sapphire II enhancer solution, which could because the 
585 nm peak is overlaid with the shoulder of the fluorophore in the Emerald II enhancer and 
increasing the enhancer will lead to the rising the fluorophore peak, and as a result, the ratio will 
slightly decrease. Our goal for this project is using this established system to quantify pH in a 
biological system. The ability to keep the ratio constant in more complicated systems is important 
peak emission at 535 nm, which is closer to monitored
585 nm wavelength. The ratio of chemiluminescence emission
at 650 nm and 585 nm (CL650/CL585) was also measured in the
presence of 10% fetal bovine serum (Fig. 4C). No significant
change was observed, demonstrating selective chemilumines-
cent measurement of pH in complex biological fluids.
Finally, we established the suitability of this system for
ratiometric chemilumi escence imaging of pH using an IVIS
Spectrum. Images were rapidly acquired using either a 580 nm
filter or a 640 nm filter. Carboxy-SNARF-1, 1, and either
Sapphire II Enhancer (Fig. 5) or Emerald II Enhancer (Fig. 6)
in aqueous solutions buffered at pH 6, 6.4, 6.8, 7.2, 7.4, 7.6,
7.8, or 8.0. Six replicates of each pH were imaged in a single
plate.
Short acquisition times of 2 seconds were used to minimize
the time between image capture. Generally, light emission
increases with increasing pH when using both the 580 nm
filter (Fig. 5A and 6A) and the 640 nm filter (Fig. 5B and 6B).
Plotting the ratio of intensities of the two images for a given
well results in a H-dependent curve that shows an increase in
the ratiometric signal (CL640/CL580) from 3 to 12 when using
the Sapphire II Enhancer (Fig. 7A) and from 0.7 to 2.1 when
using the Emerald II Enhancer (Fig. 7B). These data demon-
strate that the pH can be quantified at defined spatial
locations using this chemiluminescent system and the
described ratiometric imaging protocol.
Fig. 4 Ratiometric pH measurement in different environments. (A)
Ra io of the chemilumin scence emission intensities at 650 nm and
585 nm of 60 µM 1 and 80 µM carboxy-SNARF-1 in pH 7.42 buffers con-
taining 6%–14% Sapphire II Enhancer. (B) Ratio of the chemilumines-
cence emission intensities at 650 nm and 585 nm of 60 µM 1 and 80 µM
carboxy-SNARF-1 in pH 7.42 buffers containing 6%–14% Emerald II
Enhancer. (C) Ratio of the chemiluminescence emission intensity at
650 nm and 585 nm of 60 µM 1 and 80 µM carboxy-SNARF-1 in 20 mM
PBS buffered to pH 7.4 contai ing 6% Emerald II Enhancer in the
absence and presence of 10% fetal bovine serum (FBS).
Fig. 5 Chemiluminescence images of the pH dependent emission of
30 µM 1 and 40 µM carboxy-SNARF-1 in aqueous buffers (pH
5.99–8.01) containing 6% Sapphire II Enhancer using a (A) 580 nm filter
or (B) 640 nm filter in an IVIS Spectrum.
Fig. 6 Chemiluminescence images of the pH dependent emission of
30 µM 1 and 40 µM carboxy-SNARF-1 in aqueous buffers (pH
5.99–8.01) containing 6% Emerald II Enhancer using a (A) 580 nm filter
or (B) 640 nm filter in an IVIS Spectrum.
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for this approach. FBS (fetal bovine serum) is the main nutrition for the cell in mammalian cell 
maintenance, and it contains a variety of proteins. We can imitate the biological system by adding 
FBS to the PBS buffer and test our system in this solution. Constant pH with the addition of 10% 
FBS to the PBS buffer has been confirmed with a pH meter. We tested our system with Emerald 
II enhancer. The results show that the addition of FBS doesn’t cause any change to the ratio of 
CL650nm/CL585nm in our system, which demonstrates that we can used this system in a more 
complicated biological system. 
 
2.2.7 In vitro testing under IVIS spectrum 
 
Figure 2- 6.  Chemiluminescence images of the pH dependent emission of 30 μM 1 and 40 μM 
carboxy-SNARF-1 in aqueous buffers (pH 5.99–8.01) containing 6% Sapphire II Enhancer using 
a (A) 580 nm filter or (B) 640 nm filter in an IVIS Spectrum. 
 
peak emission at 535 nm, which is closer to monitored
585 nm wavelength. The ratio of chemiluminescence emission
at 650 nm and 585 nm (CL650/CL585) was also measured in the
presence of 10% fetal bovine serum (Fig. 4C). No significant
change was observed, demonstrating selective chemilumines-
cent measurement of pH in complex biological fluids.
Finally, we established the suitability of this system for
ratiometric chemiluminescence imaging of pH using an IVIS
Spectrum. Images were rapidly acquired using either a 580 nm
filter or a 640 nm filter. Carboxy-SNARF-1, 1, and either
Sapphire II Enhancer (Fig. 5) or Emerald II Enhancer (Fig. 6)
in aqueous solutions buffered at pH 6, 6.4, 6.8, 7.2, 7.4, 7.6,
7.8, or 8.0. Six replicates of each pH were imaged in a single
plate.
Short acquisition times of 2 seconds were used to minimize
the time between image capture. Generally, light emission
increases with increasing pH when using both the 580 nm
filter (Fig. 5A and 6A) and the 640 nm filter (Fig. 5B and 6B).
Plotting the ratio of intensities of the two images for a given
well results in a pH-dependent curve that shows an increase in
the ratiometric signal (CL640/CL580) from 3 to 12 when using
the Sapphire II Enhancer (Fig. 7A) and from 0.7 to 2.1 when
using the Emerald II Enhancer (Fig. 7B). These data demon-
strate that the pH can be quantified at defined spatial
locations using this chemiluminescent system and the
described ratiometric imaging protocol.
Fig. 4 Ratiometric pH measurement in different environments. (A)
Ratio of the chemiluminescence emission intensities at 650 nm and
585 nm of 60 µM 1 and 80 µM carboxy-SNARF-1 in pH 7.42 buffers con-
taining 6%–14% Sapphire II Enhancer. (B) Ratio of the chemilumines-
cence emission intensities at 650 nm and 585 nm of 60 µM 1 and 80 µM
carboxy-SNARF-1 in pH 7.42 buffers containing 6%–14% Emerald II
Enhancer. (C) Ratio of the chemiluminescence emission intensity at
650 nm and 585 nm of 60 µM 1 and 80 µM carboxy-SNARF-1 in 20 mM
PBS buffered to pH 7.4 containing 6% Emerald II Enhancer in the
absence and presence of 10% fetal bovine serum (FBS).
Fig. 5 Chemiluminescence images of the pH dependent emission of
30 µM 1 and 40 µM carboxy-SNARF-1 in aqueous buffers (pH
5.99–8.01) containing 6% Sapphire II Enhancer using a (A) 580 nm filter
or (B) 640 nm filter in an IVIS Spectrum.
Fig. 6 Chemiluminescence images of the pH dependent emission of
30 µM 1 and 40 µM carboxy-SNARF-1 in aqueous buffers (pH
5.99–8.01) containing 6% Emerald II Enhancer using a (A) 580 nm filter
or (B) 640 nm filter in an IVIS Spectrum.
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Figure 2- 7.  Chemiluminescence images of the pH dependent emission of 30 μM 1 and 40 μM 
carboxy-SNARF-1 in aqueous buffers (pH 5.99–8.01) containing 6% Emerald II Enhancer using 




Figure 2- 8. The pH dependent chemiluminescence emission ratio of the emission at 640 nm to 
580 nm of 30 μM 1 and 40 μM carboxy-SNARF-1 in aqueous buffers (pH 5.99–8.01) containing 
(A) 6% Sapphire II Enhancer or (B) 6% Emerald II Enhancer in an IVIS Spectrum. 
 
Finally, we proceeded to test the system in an IVIS Spectrum. The IVIS Spectrum is an 
ultra-sensitive camera that can capture the light emission at a very dim scale. It has filters with 
different wavelength in front of the camera that can control the wavelength of the light that the 
instrument will capture. We prepared the system in aqueous enhancer solution at pH 6, 6.4, 6.8, 
peak emission at 535 nm, which is closer to monitored
585 nm wavelength. The ratio of chemiluminescence emission
at 650 nm and 585 nm (CL650/CL585) was also measured in the
presence of 10% fetal bovine serum (Fig. 4C). No significant
change was observed, demonstrating selective chemilumines-
cent measurement of pH in complex biological fluids.
Finally, we established the suitability of this system for
ratiometric chemiluminescence imaging of pH using an IVIS
Spectrum. Images were rapidly acquired using either a 580 nm
filter or a 640 nm filter. Carboxy-SNARF-1, 1, and either
Sapphire II Enhancer (Fig. 5) or Emerald II Enhancer (Fig. 6)
in aqueous solutions buffered at pH 6, 6.4, 6.8, 7.2, 7.4, 7.6,
7.8, or 8.0. Six replicates of each pH were imaged in a single
plate.
Short acquisition times of 2 seconds were used to minimize
the time between image capture. Generally, light emission
increases with increasing pH when using both the 580 nm
filter (Fig. 5A and 6A) and the 640 nm filter (Fig. 5B and 6B).
Plotting the ratio of intensities of the two images for a given
well results in a pH-dependent curve that shows an increase in
the ratiometric signal (CL640/CL580) from 3 to 12 when using
the Sapphire II Enhancer (Fig. 7A) and from 0.7 to 2.1 when
using the Emerald II Enhancer (Fig. 7B). These data demon-
strate that the pH can be quantified at defined spatial
locations using this chemiluminescent system and the
described ratiometric imaging protocol.
Fig. 4 Ratiometric pH measurement in different environments. (A)
Ratio of the chemiluminescence emission intensities at 650 nm and
585 nm of 60 µM 1 and 80 µM carboxy-SNARF-1 in pH 7.42 buffers con-
taining 6%–14% Sapphire II Enhancer. (B) Ratio of the chemilumines-
cence emission intensities at 650 nm and 585 nm of 60 µM 1 and 80 µM
carboxy-SNARF-1 in pH 7.42 buffers containing 6%–14% Emerald II
Enhancer. (C) Ratio of the chemiluminescence emission intensity at
650 nm and 585 nm of 60 µM 1 and 80 µM carboxy-SNARF-1 in 20 mM
PBS buffered to pH 7.4 containing 6% Emerald II Enhancer in the
absence and presence of 10% fetal bovine serum (FBS).
Fig. 5 Chemiluminescence images of the pH dependent emission of
30 µM 1 and 40 µM carboxy-SNARF-1 in aqueous buffers (pH
5.99–8.01) containing 6% Sapphire II Enhancer using a (A) 580 nm filter
or (B) 640 nm filter in an IVIS Spectrum.
Fig. 6 Chemiluminescence images of the pH dependent emission of
30 µM 1 and 40 µM carboxy-SNARF-1 in aqueous buffers (pH
5.99–8.01) containing 6% Emerald II Enhancer using a (A) 580 nm filter
or (B) 640 nm filter in an IVIS Spectrum.
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Herein, we have realized quantitative ratiometric chemilumi-
nescence imaging of pH via the transfer of energy from a
chemiluminescent excited state of a phenolate derived from
the decomposition of 1 to the ratiometric pH sensitive dye
carboxy-SNARF-1. The synthesis and isolation of 1 was of key
importance in providing a bright chemiluminescent system to
ensure excitation of carboxy-SNARF-1. The system provides a
reliable ratiometric response to variable pH and is indepen-
dent of confounding variables such as time and the concen-
tration of the dioxetane. The system also provides an accurate
measurement of pH in the presence of fetal bovine serum,
demonstrating operational compatibility with complex biologi-
cal fluids. Protocols have been established for the quantifi-
cation of pH using chemiluminescence imaging on an IVIS
Spectrum. Due to increased luminescence emission in the
range between 585 nm and 650 nm, the system containing the
Emerald II Enhancer provides greater signal-to-noise for pH
measurement. On the other hand, the system containing the
Sapphire II Enhancer provides a higher magnitude change in
the ratiometric signal. Some fluctuations are seen when the
volumes of the Enhancer solutions are altered, a problem that
is more severe in the case of the Emerald II Enhancer. The for-
mulation of systems with stable polymeric encapsulation or
covalent linkage of components to ensure consistent stoichio-
metry could provide solutions to this issue. Nevertheless,
quantitative imaging of pH using this ratiometric chemilumi-
nescent system has been achieved. We ultimately anticipate
that similar strategies will be compatible with the current
library of known ratiometric fluorescent probes to provide a
powerful new toolkit for ratiometric chemiluminescence
imaging.
Experimental section
General materials and methods
All reactions were performed in dried glassware under an
atmosphere of dry N2. Silica gel P60 (SiliCycle) was used for
column chromatography and Analytical Chromatography TLC
Silica gel 60 F254 (Merck Millipore, Darmstadt, Germany) was
used for analytical thin layer chromatography. Plates were visu-
alized by fluorescence quenching under UV light or by staining
with iodine. Other reagents were purchased from Sigma-
Aldrich (St Louis, MO), Alfa Aesar (Ward Hill, MA), EMD
Millipore (Billerica, MA), and Oakwood Chemical (West
Columbia, SC) and used without further purification. Carboxy-
SNARF-1 was synthesized according to a literature procedure
as a mixture isomers.41 1H NMR and 13C NMR spectra for
characterization of new compounds and monitoring reactions
were collected in CDCl3 (Cambridge Isotope Laboratories,
Cambridge, MA) on a JEOL 500 MHz spectrometer or a Bruker
400 MHz spectrometer in the Department of Chemistry at
Southern Methodist University. All chemical shifts are reported
in the standard notation of parts per million using the peak of
residual proton signals of the deuterated solvent as an internal
reference. Coupling co stant units are in Hertz (Hz) Splitting
patterns are indicated as follows: br, broad; s, singlet; d,
doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of
doublets; dt, doublet of triplets. High resolution mass spec-
troscopy was performed on a Shimadzu IT-TOF (ESI source)
and low resolution mass spectroscopy was performed on a
Shimadzu LCMS-8050 Triple Quadrupole LCMS (ESI source) or
a Shimadzu Matrix Assisted Laser Desorption/Ionization MS
(MALDI) at the Shimadzu Center for Advanced Analytical
Chemistry at the University of Texas, Arlington.
(1r,3r,5R,7S)-2-((4-Chloro-3-methoxymethylphenyl) (methoxy)
methylene)adamantine (3). DIPEA (1.00 mL, 5.7 mmol,
1.8 equiv.) was added to a solution of compound 2 (954 mg,
3.1 mmol, 1.0 equiv.) in 10 mL DCM at room temperature
under N2. Then, chloromethoxymethane (0.47 mL, 6.2 mmol,
2.0 equiv.) was added dropwise to the solution at 0 °C. After
the addition of chloromethoxymethane, the reaction was
raised to room temperature and stirred for 2.5 hours. Then,
the reaction was quenched with 30 mL saturated aq NH4Cl,
extracted with 3 × 30 mL DCM, and concentrated under
reduced pressure. Purification by silica column chromato-
graphy (1 : 12 EtOAc/Hexane) yielded compound 3 as a color-
less oil (662 mg, 61%). 1H NMR (500 MHz, CDCl3) δ 7.32 (d,
1H, J = 10 Hz), 7.16 (s, 1H), 6.91 (d, 1H, J = 10 Hz), 5.25 (s, 2H),
3.53 (s, 3H), 3.31 (s, 3H), 3.24 (s, 1H), 2.66 (s, 1H), 1.69–1.95
(m, 12H); 13C NMR (125 MHz, CDCl3) δ 152.47, 142.52, 135.29,
132.53, 129.63, 123.69, 122.53, 117.55, 95.35, 57.82, 56.34,
39.07, 38.96, 37.10, 32.29, 31.04, 28.20; HRMS calcd for
C20H25ClO3 (M + H+) 349.1565, found 349.1567.
(1r,3r,5r,7r)-4′-(4-Chloro-3-(methoxymethoxy)phenyl)-4′-methoxy-
spiro [adamantane-2,3′-[1,2]dioxetane] (4). Compound 3
(207.6 mg, 0.6 mmol, 1.0 equiv.) and Rose bengal (21.2 mg,
0.02 mmol, 0.03 equiv.) were added into a dry two-neck flask
and dissolved in 5 mL THF. O2 was bubbled through the
solvent while illuminated with a 120 W light bulb (Home
Depot, Dallas, TX) at 0–5 °C. The reaction was monitored by
TLC, and after 4 hours, the mixture was concentrated at 0 °C.
Purification by silica column chromatography (1 : 15 EtOAc/
Hexane) delivered compound 4 as a yellow oil (205.6 mg, 91%).
Fig. 7 The pH dependent chemiluminescence emission ratio of the
emission at 640 nm to 580 nm of 30 µM 1 and 40 µM carboxy-SNARF-1
in aqueous buffers (pH 5.99–8.01) cont ining (A) 6% Sapphire II
Enhancer or (B) 6% Emerald II Enhancer in an IVIS Spectrum.
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7.2, 7.4, 7.6, 7.8, or 8.0 in PBS buffer with 6 % Sapphire II enhancer, 30 μM dioxetane 1 and 40 
μM carboxy-SNARF-1. The IVIS Spectrum could capture the picture of light emission at 580 nm 
and 640 nm. In the Sapphrie II enhancer solution, the light emission intensity at 580 nm is much 
lower than 640 nm (Figure 2-6, A-B). Each pH has 6 replicates in this test. The computer program 
can calculate the sum of light emission from each well, and by plotting out the ratio of 
CL640nm/CL580nm, a graph has been obtained and a 4-fold increase of CL640nm/CL580nm ratio from 
pH 6-8 has been observed (Figure 2-8, A). Similar results have been observed with Emerald II as 
the enhancer (Figure 2-7, A-B) and according to the graph (Figure 2-8, B), a 3-fold increase of 
CL640nm/CL580nm ratio from pH 6-8 is obtained. 
 
2.3 Conclusions 
Herein, we have realized quantitative ratiometric chemiluminescence imaging of pH via 
the transfer of energy from a chemiluminescent excited state of a phenolate derived from the 
decomposition of 1 to the ratiometric pH sensitive dye carboxy-SNARF-1. The synthesis and 
isolation of 1 was of key importance in providing a bright chemiluminescent system to ensure 
excitation of carboxy-SNARF-1. The system provides a reliable ratiometric response to variable 
pH, which is independent of confounding variables such as time and the concentration of the 
chemiluminescent probe. The system also provides an accurate measurement of pH in the presence 
of fetal bovine serum, demonstrating operational compatibility with complex biological fluids. 
Protocols have been established for the quantification of pH using chemiluminescence imaging on 
an IVIS Spectrum. Due to increased luminescence emission in the range between 585 nm and 650 
nm, the system containing the Emerald II Enhancer provides greater signal-to-noise for pH 
measurement. On the other hand, the system containing the Sapphire II Enhancer provides a higher 
magnitude change in the ratiometric signal. Some fluctuations are seen when the volumes of the 
Enhancer solutions are altered, a problem that is more severe in the case of the Emerald II Enhancer. 
The formulation of systems with stable polymeric encapsulation or covalent linkage of 
components to ensure consistent stoichiometry could provide solutions to this issue. Nevertheless, 
quantitative imaging of pH using this ratiometric chemiluminescent system has been achieved. We 
ultimately anticipate that similar strategies will be compatible with the current library of known 




2.4 Synthesis Procedures 
2.4.1 General materials and methods 
All reactions were performed in dried glassware under an atmosphere of dry N2. Silica gel P60 
(SiliCycle) was used for column chromatography and SiliCycle 60 F254 silica gel (precoated 
sheets, 0.25 mm thick) was used for analytical thin layer chromatography. Plates were visualized 
by fluorescence quenching under UV light or by staining with iodine. Other reagents were 
purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward Hill, MA), EMD Millipore 
(Billerica, MA), Oakwood Chemical (West Columbia, SC), and Cayman Chemical (Ann Arbor, 
MI) and used without further purification. 1H NMR and 13C NMR spectra for characterization of 
new compounds and monitoring reactions were collected in CDCl3 (Cambridge Isotope 
Laboratories, Cambridge, MA) on a JEOL 500 MHz spectrometer in the Department of Chemistry 
at Southern Methodist University. All chemical shifts are reported in the standard notation of parts 
per million using the peak of residual proton signals of the deuterated solvent as an internal 
reference. Coupling constant units are in Hertz (Hz) Splitting patterns are indicated as follows: br, 
broad; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublets; dt, doublet 
of triplets. High resolution mass spectroscopy was performed on a Shimadzu IT-TOF (ESI source) 
and low resolution mass spectroscopy was performed on a Shimadzu LCMS-8050 Triple 
Quadrupole LCMS (ESI source) or a Shimadzu Matrix Assisted Laser Desorption/Ionization MS 





methoxybenzaldehyde (1502 mg, 8.8 mmol, 1 equiv) was dissolved with 5 mL MeOH in a dry 
flask filled with N2. Trimethyl orthoformate (0.96 mL, 9.3 mmol, 1.1 equiv) and p-Toluenesulfonic 
acid (147 mg, 0.9 mmol, 0.1 equiv) was added to the flask. The mixture was stirred for 24 hours 







NaHCO3 to the mixture and extract with 3 x 30 mL EtOAc. The organic layer was dried by Na2SO4, 
filtered and concentrated under reduced pressure to obtain crude acetal 3(1897.4 mg). Compound 
3 was dissolved in 5 mL DCM at 0°C. Triethyl phosphite (1.65 mL, 10.2 mmol, 1.2 equiv) and 
boron trifluoride etherate (1.13 mL, 9.00 mmol, 1.0 equiv) were added to the flask at 0°C. The 
reaction was raised to 30°C and stirred for 1 hour. The reaction was quenched by 30 mL NaHCO3, 
extracted by 3 x 30 mL EtOAc and dried by Na2SO4 and filtered. Evaporate the EtOAc under 
reduced pressure and purify by column chromatography (1:15 EtOAc/Hexane) yield the product 
as a pale yellow oil (13389 mg, 47%). 1H NMR (500 MHz, CDCl3) d 7.23 (d, 1H, J = 8.1 Hz), 
6.98 (t, 1H, J = 2.0 Hz), 6.83 (dt, 1H, J = 6.3, 2.0 Hz), 4.37 (d, 1H, J = 16.1 Hz), 3.86–4.00 (m, 
4H), 3.81 (s, 3H), 3.29 (s, 3H), 1.11–1.26 (m, 6H); 13C NMR (125 MHz, CDCl3) d 154.82, 134.40, 
129.72, 122.29, 120.74, 111.12, 80.44, 79.43, 63.05 (d, J = 10.7 Hz), 62.81 (d, J = 10.7 Hz), 58.65 
(d, J = 14.3 Hz), 55.97, 16.26 (d, J = 5.9 Hz), 16.18 (d, J = 5.9 Hz); HRMS calcd for C13H20ClO5P 




(5). Compound 4 (1339 mg, 4.2 mmol, 1.0 equiv) was dissolved in 5 mL anhydrous THF in a dry 
flask under N2 and cooled to –78 °C by adding dry ice to acetone. 2-Adamantanone (786 mg, 5.2 
mmol, 1.2 equiv) was dissolved in 5 mL anhydrous THF and cooled to –78 °C by the same way. 
Add 5 mL 1.6 M n-BuLi to the compound 4 solvent at –78 °C and stirred for 6 min. Add the cooled 
2-adamantanone solvent to the flask and raise the temperature of the reactant to 30 °C. The mixture 
was stirred for 2 hours and the temperature was raised to 90 °C under reflux. After 1 hour reflux, 
the reaction was quenched by 30 mL NH4Cl and extracted by 3 x 30 mL EtOAc. Purification by 
chromatography (1:15 EtOAc/Hexane) yield Compound 5 as colorless oil (1351 mg, >95%). 1H 
NMR (500 MHz, CDCl3) d 7.30 (d, 1H, J = 8.0 Hz), 6.91 (d, 1H, J = 1.8 Hz), 6.83 (dd, 1H, J = 
8.0, 1.8 Hz), 3.89 (s, 3H), 3.30 (s, 3H), 3.24 (s, 1H), 2.62 (s, 1H), 1.58–1.97 (m, 12H); 13C NMR 
(125 MHz, CDCl3) d 154.84, 142.77, 135.44, 132.56, 129.62, 122.54, 121.41, 112.82, 57.90, 56.16, 









5-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-chlorophenol (6). Compound 5 
(1351 mg, 4.2 mmol, 1.0 equiv) was dissolved in 14.4 mL anhydrous DMF at room temperature 
in a dry flask under N2. Cs2CO3 (3436 mg, 10.5 mmol, 2.5 equiv) and EtSNa (867 mg, 10.3 mmol, 
2.5 equiv) was added to the flask. The temperature of the mixture was raised to 90 °C under reflux 
for 16 hours. The reaction was quenched by 30 mL of NH4Cl, extracted by 3 x 30 mL, dried over 
Na2SO4 and evaporated under reduced pressure. Purification by column chromatography (1:15 
EtOAc:Hexane) yield compound 6 as a white solid (954 mg, 74%). 1H NMR (500 MHz, CDCl3) 
d  7.28 (d, 1H, J = 8.0 Hz), 6.98 (d, 1H, J = 3.5 Hz), 6.83 (dd, 1H, J = 8.0, 3.5 Hz) 5.95 (s, 1H), 
3.30 (s, 3H), 3.22 (s, 1H), 2.62 (s, 1H), 1.55–1.96 (m, 12H); 13C NMR (125 MHz, CDCl3) d 151.12, 
142.18, 135.88, 132.79, 128.57, 122.38, 118.84, 116.97, 57.80, 39.08, 38.94, 37.04, 32.22, 30.21, 




DIPEA (1.00 mL, 5.7 mmol, 1.8 equiv) was added to a solution of compound 6 (954 mg, 3.1 mmol, 
1.0 equiv) in 10 mL DCM at room temperature under N2. Chloromethoxymethane (0.47 mL, 6.2 
mmol, 2.0 equiv) was added dropwise to the solvent at 0 °C. After the addition of 
chloromethoxymethane, the reaction was raised to room temperature and stirred for 2.5 hours. 
Quench the reaction with 30 mL saturated aq NH4Cl and the mixture was extracted with 3 x 30 
mL DCM and evaporated under reduced pressure. Purification by chromatography (1:12 
EtOAc/Hexane) yielded compound 7 as a colorless oil (662 mg, 61%). 1H NMR (500 MHz, CDCl3) 
d 7.30 (d, 1H, J=10.0 Hz), 7.12 (s, 1H), 6.90 (dd, 1H, J=10 Hz), 5.21 (s, 2H), 3.55 (s, 3H), 3.28 (s, 
3H), 3.22 (s, 1H), 2.62 (s, 1H), 1.69-1.95 (m, 12H); 13C NMR (125 MHz, CDCl3) d 151.48, 135.64, 
129.02, 121.20, 111.53, 95.57, 50.02, 47.10, 39.38, 36.43, 34.82, 33.21, 32.34, 31.75, 31.61, 31.04, 













Compound 7 (208 mg, 0.6 mmol, 1.0 equiv) and Rose Bengal (21.2 mg, 0.02 mmol, 0.03 equiv) 
were added into a dry two-neck flask and dissolved in 5 mL THF. O2 was bubbled through the 
solvent while illuminated with a 120W light bulb (Home Depot, Dallas, TX) at 0–5 °C. Monitor 
the reaction by TLC. After 4 hours, the mixture was concentrated at 0 °C. Purification by silica 
column chromatography (1:15 EtOAc/Hexane) delivered compound 8 as a yellow oil (206 mg, 
91%). 1H NMR (500 MHz, CDCl3), d 7.01–7.64 (m, 3H, br), 5.28 (m, 2H), 3.49 (s, 3H), 3.20 (s, 
3H), 3.01, (s, 1H), 2.12 (s, 1H), 1.45-1.90 (m, 12H); 13C NMR (125 MHz, CDCl3) d 152.62, 134.80, 
130.13, 125.03, 111.61, 95.47, 56.30, 49.98, 39.50, 35.43, 33.24, 33.11, 31.71, 31,58, 30.30, 26.08, 
26.00.  MS not found. 
 
 
Compound 8 (651 mg, 1.7 mmol, 1.0 equiv) was dissolved in 10 mL MeOH at room temperature. 
p-toluenesulfonic acid (37.3 mg, 0.2 mmol, 0.1 equiv) was dissolved in 10 mL MeOH at room 
temperature. The p-toluenesulfonic acid solvent was added to the compound 7 drop by drop. After 
addition of p-toluenesulfonic acid, the mixture was raised to 65 °C and stirred for 6.5 hours. The 
mixture was quenched by 50 mL brine and extracted by 3 x 50 mL EtOAc and evaporated under 
reduced pressure. Purification was by silica column chromatography (1:20 EtOAc/Hexane). 
Compound 1 was obtained as a white solid (303 mg, 53%). 1H NMR (500 MHz, CDCl3) d 7.02–
7.53 (m, 3H, br), 5.81 (s, 1H), 3.22 (s, 3H), 3.05 (s, 1H), 2.17 (s, 1H), 1.43–1.83 (m, 12H); 13C 
NMR (125 MHz, CDCl3) d 151.42, 135.70, 121.20, 111.52, 95.71, 50.04, 47.05, 39.20, 36.44, 

















4-[4-(dimethylamino)-2-hydroxybenzoyl]- 1,3-Benzenedicarboxylic acid (9). 
1,2,4-Benzenetricarboxylic anhydride (2105 mg, 11.0 mmol, 1.0 equiv) and 3-
(Dimethylamino)phenol (1505 mg, 11.0 mmol, 1.0 equiv) were added to a dry flask and dissolved 
with 30.0 mL toluene. The mixture was raised to 120 °C and stirred overnight. The mixture was 
washed by toluene 3 x 30 mL, 3 x 50 mL DCM and 3 x 50 mL EtOAc and filter the product and 
vacuum dry. Purification was by silica gel column chromatography (1:18 MeOH:DCM). 
Compound 9 was obtained as a dark green solid (3126 mg, 79%). 1H NMR (500 MHz, CDCl3) d 
12.36 (s, 1H), 12.33 (s, 1H), 6.76–8.50 (m, 6H), 6.07 (s, 1H), 2.97 (d, 6H, J=2.5). 
 
 
1,3-Benzenedicarboxylic acid, 4-[4-(dimethylamino)-2-hydroxybenzoyl] (2657 mg, 8.1 mmol, 
1.0 equiv) and 1,6-naphthalenediol (1383 mg, 8.6 mmol, 1.1 equiv) were added to a dry, vacuum 
and N2 filled flask. Later 5 mL of MeSO3H was added to the flask and stirred for 3 hrs. The mixture 
was washed by water 3 x 30mL, EtOAc 3 x 30 mL and DCM 30 mL. Purification was by column 
chromatography (1:4 MeOH:DCM) and yielded carboxy-SNARF-1 as a purple solid (340 mg, 
9%). 1H NMR (500 MHz, CDCl3) d 10.35 (s, 1H), 10.21 (s, 1H), 6.56–8.42 (m, 11H), 6.96 (s, 1H), 
3.32 (s, 6H). 
 
2.4.2 Imaging experiments with Fluorescence Spectroscopy 
Chemiluminescent responses were acquired with a Hitachi F-7000 Fluorescence 
Spectrophotometer (Hitachi, Tokyo, Japan) using the luminescence detection mode. The 
Spectrophotometer scan mode was set as wavelength scan with the range of emission wavelength 


















pH 5.5 was made from 0.2 M Citric Acid – Sodium Citrate Buffer Solutions while pH 6.0 – 8.0 
was made from 0.2 M PBS buffer solution and pH 9.2 – 10 was made from 0.1 M Sodium 
Carbonate – Sodium Bicarbonate Buffer Solutions. 
 
2.4.3 pH dependence property 
463 µL buffer, 30 µL of Emerald II enhancer or Sapphire II enhancer, 4 µL carboxy-
SNARF-1 solvent (10mM) in DMSO and 3 µL 10mM Compound-1 in DMSO were added to a 
quartz cuvette (Starna, Atascadero, CA). The cuvette was shaken gently to assure mixing. The 
cuvette was placed in the middle of the Spectrophotometer and obtained the wavelength scan graph. 
The procedure was repeated with all the buffers in different pH. 
 
2.4.4 Time independence property 
463 µL PBS buffer solution, 30 µL of Emerald II enhancer or Sapphire II enhancer, 4 µL 
carboxy-SNARF-1 solvent (10mM) in DMSO and 3 µL Compound-1 solution (10mM) in 
DMSO were added to a quartz cuvette (Starna, Atascadero, CA). The cuvette was shaken gently 
to mixed. The cuvette was placed in the spectrophotometer and the wavelength scan mode was run 
every 3 mins for ten times. 
 
2.4.5 Probe independence property 
465 µL 0.2 M pH 7.4 PBS buffer solution, 30 µL Emerald II enhancer or Sapphire II 
enhancer, 4 µL carboxy-SNARF-1 solution (10 mM) in DMSO and 1 µL Compound-1 solution 
(10 mM) in DMSO were added to a quartz cuvette (Starna, Atascadero, CA). The cuvette was 
shaken gently to assure mixing. The cuvette was placed in the center of spectrophotometer and 
obtained the wavelength scan graph and repeat the experiment with increasing amount of 
Compound-1 solution from 1 µL to 10 µL (1 µL each time) and decreasing amount of buffer 
solution from 465 µL to 456 µL (1 µL each time).  
 
2.4.6 Imaging experiments with IVIS Spectrum 
Chemiluminescent responses were acquired with an IVIS Spectrum (Caliper, Waltham, MA) using 
the “Luminescent” and “Photograph” mode. The exposure time was set as 2 seconds, and the 
binning was set to small. The F/stop was set to 4, and the FOV was set to C, which means the field 
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of view was set to 13 cm. With these settings, images could be acquired with 267 μM spatial 
resolution. The height of each photograph was 1.5 cm. The excitation was blocked and a sequence 
was set for the emission mode. The sequence was set as 580 nm, 640 nm, 580 nm, 640 nm, 580 
nm and 640 nm. 231.5 μL aliquots of PBS buffers with pH from 5.99–8.01 were added to the wells 
on the 96-well plate from A1 to A8. Later 2 μL of a 5 mM stock solution of carboxy-SNARF-1 
(80 μM final concentration) in DMSO was added to each well followed by the addition of 15 μL 
Emerald II Enhancer or Sapphire II Enhancer. Next 1.5 μL of a 5 mM stock solution of 1 in DMSO 
was added to each well after the adding of the buffer, enhancer and carboxy-SNARF-1. This was 
repeated in groups A1 to A8 for 6 times on each plate. The sequence described above was acquired 
and the images were analyzed using the Living Image software.  
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Chapter 3 A Chemiluminescent Probe for HNO Quantification 
and Real-time Monitoring in Living Cells 
3.1 Introduction 
3.1.1 What is HNO 
Nitroxyl (HNO) is the reductive product of NO with the addition of one electron and one 
proton. NO– is isoelectronic to molecular oxygen and has a triplet ground state, which raises the 
pKa of HNO to 11.1 HNO will dimerize and eliminate water to rapidly form nitrous oxide (N2O) 
(k = 8 x 106 M–1s–1 at 23 ºC).2 At pH > 11, the 3NO– will react with 3O2 and yielded ONOO–. 3,4 
Thiols5 and iron in heme-containing proteins6 are two main biological targets for HNO.  
 
3.1.2 Biological and pharmacological functions of HNO 
NO has been recognized as a vasodilator and endothelium-derived relaxing factor (EDRF) 
since the 1980s. NO can activate the heme protein soluble guanylyl cyclase (sGC) and can lead to 
the conversion of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), a 
key factor to initiate a cascade of biological activities that result in vasodilation.7 Studies have 
been done with isolated sGC exposed to donors like HNO, NO and NO+, and the results showed 
that the sGC will be activated only when exposed to NO.8 This result implies that the HNO induced 
vasodilation is because of the oxidation of HNO to NO in tissue that leads to the generation of 
cGMP and result in the sGC activating.9 A range of biological reagents could help HNO to convert 
to NO including SOD, metHP and flavins.10 However only small portion (<5%) of HNO could be 
converted to NO in biological conditions,10 which leads to the question that if HNO itself could 
directly lead to the vessel relaxation. Recent evidence supports the possibility that HNO could 
regulate vascular tone and blood flow through an HNO/TRPA1/CGRP pathway.11-12 
Pharmacological HNO can be used as a pain reducer in animal models through a cGMP/PKG/KATP 
pathway.13 Pharmacological HNO is being investigated as a treatment for heart failure. The release 
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of CGRP has been observed from rat aortic strips upon exposure to HNO, which is a key factor to 
cause visodilation.14 Cyanamide has been used as an alcohol deterrent agent. With the existence 
of catalase and H2O2, cyanamide will release HNO as an aldehyde dehydrogenase (AIDH) 
inhibitor.15 HNO can also be cytotoxic since it will affect the cellular function by changing redox 
status of cell, but this process will be protected by GSH that works as an HNO scavenger.16 
 
3.1.3 Possible endogenous HNO resources 
A range of endogenous biomolecules can lead to the generation of HNO. Endogenous 
generation of HNO could result from the reaction between H2S with NO has been suggested to 
have a biological role in a HNO/TRPA1/CGRP pathway.11-12 The reaction between NH2OH and 
NO could also be a endogenous resource for HNO, even with a low generation rate (5 × 10−3 M−1 
s−1 at 25 ◦C, pH 7.3).17-18 Although free Fe (II) has a low concentration in biological systems, it is 
still capable of reducing NO to HNO due to the stoichiometric conversion.19-20 The S-nitrosothiol 
is another source for endogenous HNO upon the reaction with excess endogenous thiols at a 
comparability low reaction rate (8.3 × 10−3 M−1 s−1).21 Meanwhile, the reaction of GSNO and 
GSH22, GSNO and NADH23 also contribute to the generation of endogenous HNO. However, even 
though the generation of HNO has been confirmed with isolated donors, the low reaction rate and 
low concentration of the reactant limited the possibility of occurrence in biological system. As a 
result, HNO detection methods have started to attract attention from researchers. 
 
3.1.4 HNO detection methods and difficulties  
The fast dimerization rate (k = 8 X 106 M–1s–1 at 23 ºC)2 and rapid reaction rate with 
molecular oxygen (range from 103 to 104 M–1s–1)5, 24 for HNO in biological systems make its 
detection challenging. Researchers have developed various methods to detect the biological HNO 
reaction products instead of directly detecting HNO due to its instability. The dimerization product 
N2O is a good indicator for HNO generation, which has been successfully detected by gas 
chromatography and with electron paramagnetic resonance (EPR) spectroscopy trapping by N-
methyl-D-glucamine dithiocarbamate iron (Fe-MGD) to produce ERP active molecules.25 Even 
though the detection of N2O is applicable in solution, but application of this method in biological 
systems is limited. Glutathione sulfonamide, the product of HNO and GSH, can also be used as a 
biomarker for HNO detection with high pressure liquid-chromatography mass spectrometry 
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(HPLC-MS).26-27 However, sensitive tools for direct detection of HNO are needed to study 
potential endogenous biological pathways and functions of HNO as well as measure HNO released 
from pharmacological donor compounds. 
 
3.1.5 Current HNO probes 
A series of fluorescent HNO probes have been reported recently including copper-based 
fluorescent probes,28 phosphine-based fluorescent probes,28 TEMPOL-based fluorescent probes28 
and 2-mercapto-2-methylpropionic acid-based probes.45 
 
Scheme 3 - 1. Copper-based HNO fluorescent probe Cu(BOT1).30 
The first small molecule fluorescent HNO probe was synthesized by Lippard’s group in 
2010 based on the CuII cation (Scheme 3-1). When CuII is bounded to the tripodal dipicolylamine-
appended receptor, the fluorescence will be quenched. The CuII can quench the fluorescence of the 
molecule by photoinduced electron transfer (PET) of the singlet excited state of BODIPY. 
Cu(BOT1) has an 4-fold turn on towards 1000 equivalents of Angeli’s salt and a good selectivity 
toward HNO.30 Later a series of probes based on copper has been synthesized with a turn-on range 
of 5-fold to 15-fold at different emission wavelength.31-34 Another type of HNO probe has been 
synthesized with phosphine as the protecting group.28 The fluorescence of the fluorophore is 
quenched or diminished with the attachment of phosphine, and once reacted with HNO, the 
phosphine protecting group will be removed and released the fluorophore with a higher fluorescent 
emission.28 A series of probes based on this mechanism have been synthesized with different 
emission wavelengths.35-43 Compared with Cu-based probes, phosphine-based probes present a 
better fluorescent response. The metal free and reductant resistant trigger give it a better selectivity 
for HNO detection in biological systems (Scheme 3-2).28 TEMPOL-based fluorescent probes44 
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However, because of the instability of HNO in biological systems, a more sensitive tool for HNO 
detection is needed to study the biological pathways and function of HNO. Compared with 
fluorescent probes, chemiluminescent probes have a better signal-to-noise ratio, which could 
significantly increase the detection sensitivity. Our lab designed and synthesized the first 
chemiluminescent HNO probes, which have an over 800-fold increase toward 20 equivalents of 
Angeli’s salt compared with the control. We successfully quantified the HNO generated from H2S 
and NO and achieved HNO monitoring in biological systems.46 These results will be presented 
and discussed in this chapter. 
 
Scheme 3 - 2. HNO detection mechanism for phosphine-based probes.28 
 
3.2 Results and discussion 
3.2.1 Design and Synthesis of HNOCL-1 
Our lab aimed to develop highly sensitive probes as a powerful tool to detect and study the 
generation, pathways and biological function of reactive oxygen and nitrogen species, and a series 
of chemiluminescent probes based on 1,2-spirodioxetane have been synthesized and characterized 
before1-4. Phosphine has been used as the HNO detection group for a series of probes5-10. The 
design of HNOCL-1 consists of linking a triaryl phosphine group to the sterically stabilized 1,2-


































phenolate. In aqueous solution, the phenolate will trigger Chemically Initiated Electron Exchange 
Luminescence (CIEEL) mechanism and emit light.  
 
 
Scheme 3 - 3. Design and synthesis of HNOCL-1. 
The synthesis of HNOCL-1 started with 2-chloro-3-methoxybenzaldehyde. First, we 
treated the 4-chloro-3-methoxylbenzaldehyde 11 with trimethyl orthoformate the presence of p-
toluenesulfonic acid in methanol to yield the acetal 12. The acetal 12 was treated with triethyl 
phosphite and boron trifluoride diethyl etherate to obtain the diethyl methoxy phosphonate 13. We 
ran the Horner–Wadsworth–Emmons reaction with phosphonate, where we treated 12 with n-BuLi 
and 2-admantanone to yield the enol ether 14. The enol ether 14 would go through a demethylation 
reaction via nucleophilic substitution with sodium ethanethiolate and cesium carbonate to obtain 
the phenol 15. The enol ether was treated with N-iodosuccinimide, which yielded the iodide phenol 
16. The iodide phenol 16 went through a Heck reaction and yielded the acrylate phenol 17. The 
acrylate phenol 17 was dissolved with THF and Rose Bengal was added to the solvent as a catalyst. 
O2 was then bubbled through the system and the 1,2-spirodioxetane phenol 18 was obtained. 
Finally, the 1,2-spirodioxetane phenol 18 was treated with EDC, DMAP and 2-
















































































3.2.2 Mechanism of HNO detection 
 
Scheme 3 - 4. Proposed mechanism for the reaction of the triaryl phosphine in HNOCL-1 with 
HNO. 
Once reacted with HNO, the HNOCL-1 will turn into a self-cleavable intermediate 
azaylide which will lead to the ester cleavage and release the phenol. In aqueous solution, the 
phenol will be deprotonated and yield the phenolate, which would decompose and trigger CIEEL. 
The light emission for this compound is at 525 nm.47 
 
3.3.3 Response and selectivity 
 
Figure 3- 1. Chemiluminescence response of HNOCL-1 and Angeli's salt, Na2N2O3 (AS). (A) 
Chemiluminescence emission spectra at 525 nm of 20 µM HNOCL-1 and 0 (blue trace), 50, 100, 
150, and 200 µM (red trace) AS. (B) Time course of chemiluminescence emission of 0 (blue trace), 
5, 25, 50, and 100 µM (red trace) AS. Experiments were performed in 20 mM PBS (pH 7.4), 
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The response towards HNO was collected later after obtaining HNOCL-1. 20 µM 
HNOCL-1 was treated with 0 - 200 µM Angeli’s salt and the emission peak was observed at 525 
nm (Figure 3-1, A). The time scan at 525 nm with 0 µM, 5 µM, 25 µM, 50 µM and 100 µM of 
Angeli’s Salt shows a dose dependent response for HNOCL-1, which demonstrates the high 
sensitivity of the probe. The emission reaches the maximum emission at around 15 mins and starts 
to decay with a slower rate over the time course of 40 min (Figure 3-1, B).  
 
 
Figure 3- 2. Chemiluminescent responses of 20 µM HNOCL-1 and 200 µM reactive oxygen and 
nitrogen species. Legend: 1. AS, 2. GSH (2 mM), 3. GSNO, 4. H2O2, 5. KO2, 6. Cys (1 mM), 7. 
Na2S, 8. Na2S2O3, 9. NaNO2, 10. HO•, 11. ONOO–, 12. tBuOOH, 13. OCl–, 14. DEA NONOate, 
15. Blank. Experiments were performed in 20 mM PBS (pH 7.4), containing ≤1% DMSO. 
 
We proceeded to evaluate the selectivity of HNOCL-1 towards HNO compared with other 
biologically related reactive oxygen and nitrogen species. We treated 20 µM HNOCL-1 in PBS 
buffer (pH=7.4, 20 mM) and added different reactive oxygen and nitrogen species including 2 mM 
GSH, 1 mM cysteine and 200 µM other reactive oxygen and nitrogen species. HNOCL-1 has a 
significant increase of chemiluminescent intensity upon the addition of Angeli’s salt compared 
with other reactive oxygen and nitrogen species. The NO donor, DEA NONOate caused a slight 
increase when tested in 20 mM HEPES buffer but nothing happened in PBS buffer. The reason for 
the increase could be the reduction of NO by HEPES to yield a small amount of HNO. 
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Scheme 3 - 5. Principle of HNO detection with XF2. 
XF2 is a fluorescent probe previously synthesized by our lab to detect HNO. The 
fluorescence is quenched by attaching the diphenylphosphino group. Once reacted with HNO, the 
fluorophore will be released and the fluorescence emission will increase.  
 
 
Figure 3- 3. Chemiluminescence response of HNOCL-1 and Angeli's salt, Na2N2O3 (AS). (A) 
Time course of chemiluminescence emission of 10 µM HNOCL-1 and 0 (blue trace) or 200 µM 
(red trace) AS.  (B) Fluorescence emission spectra of 10 µM XF2 after reacting with 0 (blue trace) 
or 200 µM (red trace) AS for 25 minutes. Experiments were performed in 20 mM PBS (pH 7.4), 
containing ≤1% DMSO. 
 
Compared with XF2, HNOCL-1 has a significantly improved signal-to-noise ratio 
response towards the same amount of HNO with the integrated data at the time point 25 min. After 
the control is normalized to 1, the emission from HNOCL-1 reacted with HNO lead to an 833-
fold turn-on response. With the same concentration of probe and HNO, the XF2 only has a 20-
fold turn-on response.  
 
3.3.5 Quantification of HNO generated from NO and H2S 
 
Eq. 3-1. Equation to quantify the concentration of HNO. [HNOCL-1] is the concentration of 
HNOCL-1. [1] is the concentration of the phenol. k1 = 20,433 M–1s–1 at 25 ºC, pH 7.4 according 
to the method developed by Miranda and Wink5. k3 = 5.92 X 10–4 s–1 at 25 ºC, pH 7.4 according 
to measurements of the exponential decay of isolated 1. 
 
Because of the sensitivity of HNOCL-1, we were able to quantify the concentration of 
HNO generated from the system. The derivation of Eq. 3-1 is given in the Experimental Methods 
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[HNO] = 1/(k1[HNOCL-1]) (k3[1] + d[1]/dt) 
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concentration of the phenol, which could be determined by isolated 1 decay. The [1] could be 
determined by chemiluminescent emission intensity. The chemiluminescent emission could be 
converted to [1] with a carefully calibrated graph with varying concentration of 1 and 
chemiluminescent emission intensity (Figure 3-16). k1 = 20,433 M–1s–1 at 25 ºC, pH 7.4 and k3 = 
5.92 x 10–4 s–1 at 25 ºC.  
 
Figure 3- 4. Concentration of HNO generated from AS (A) measured from the raw 
chemiluminescence emission of 20 µM HNOCL-1 or (B) computationally simulated. 
Experiments were performed in 20 mM PBS (pH 7.4), containing ≤1% DMSO.  
 
We then measured the concentration of HNO generated from various concentrations of 
Angeli's salt according to Eq 3-1 from Figure 3-1, B. The results are shown on Figuer 3-4, A. The 
results matched the simulated results determined from numerical solution of the differential 
equation modeling HNO generation from Angeli's salt (Figure 3-4, B). 
 
 
Figure 3- 5. (A) Time course of chemiluminescent emission and (B) integrated emission intensity 
of 20 µM HNOCL-1 alone (blue trace), 200 µM Na2S alone or with 0.2, 0.5, and 1 mM (red trace) 
DN, and 200 µM Na2S, 1 mM DN, and 2 mM N-acetyl cysteine (NAC). (C) Concentration of 
HNO produced from 20 µM HNOCL-1 alone (blue trace), and 200 µM Na2S and 0.2, 0.5, and 1 
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performed in 20 mM HEPES or PBS (pH 7.4), containing ≤1% DMSO. Error bars are + S.D. 
from n = 3–6 replicates. 
 
With HNOCL-1, we successfully confirmed and quantified the generation of HNO from 
H2S and NO, which is one of the possible endogenous sources of HNO. With 200 µM Na2S and 
20 µM HNOCL-1, a significant rise in chemiluminescent emission appeared with the addition of 
DEA NONOate. It shows a dose-dependent manner with different concentrations of DEA 
NONOate. With the increasing concentration of DEA NONOate, the maximum emission increased 
and it takes shorter time to reach the emission peak (Figure 3-5, A). Once we added the N-acetyl 
cysteine (NAC), an HNO scavenger, the light emission is quenched and the signal disappeared 
(Figure 3-5, B). When we applied the light emission intensity to Eq. 3-1, the intensity of HNO 
was calculated (Figure 3-5, C). 
 
3.3.6 HNO detection in living cells 
 
Figure 3- 6. Chemiluminescent measurement of HNO in living cells. (A) Time course of 
chemiluminescent emission and (B) integrated emission intensity of A549 cells incubated with 20 
µM HNOCL-1 for 30 minutes, washed and treated with AS. Error bars are +S.D. from n = 9 wells 
across 3 biological replicates.  
 
We proceeded to test if HNOCL-1 is capable of detecting pharmacological HNO in 
biological systems. A549 lung cancer cells were incubated with 20 µM HNOCL-1 for 30 mins 
and were thoroughly washed with PBS buffer to remove all the extracellular probes. The cells were 
treated with various amounts of Angeli’s salt afterwards. The signal from the cells increased with 
a higher concentration of Angeli’s salt (Figure 3-6). The signal started to max out from 500 µM to 
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Figure 3- 7. Chemiluminescent measurement of HNO in living cells. (A) Time course of 
chemiluminescence emission of A549 cells incubated with 20 µM HNOCL-1 for 30 minutes, 
washed and incubated without (blue trace) or with 1 mM DEA NONOate (DN) and 200 µM Na2S 
(red trace). (B) Integrated emission intensity of A549 cells incubated with 20 µM HNOCL-1 for 
30 minutes, washed and treated as indicated with H2S as 200 µM Na2S, NO as 1 mM DN, and 
NAC at 2 mM. Error bars are +S.E. from n = 6–11 wells and 2–4 biological replicates. Statistical 
significance was assessed using a two-tailed student's t-test. **p<0.01, *p<0.05. All cellular 
experiments were performed at 37 ºC. 
 
We then continued to test if HNOCL-1 had the ability to detect the HNO generated from 
the reaction between H2S and NO in biological system. After 30 mins incubation with HNOCL-
1, the Na2S and DEA NONOate were added to the A549 lung cancer cells. The experimental group 
showed a slight rise compared to the control group. Upon the addition of N-acetyl cysteine (NAC) 
to the cells treated with Na2S and DEA NONOate, there was a significant decrease in the emission. 
These results demonstrated that HNOCL-1 has the ability to detect the HNO generated from Na2S 
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3.3.7 HNO in vivo detection 
 
Figure 3- 8. Images of BALB/c nude mice 2 minutes after IP injection with 40 µM HNOCL-1 
and (A) vehicle control or (B) 1 mM Angeli's salt in 20 mM PBS (pH 7.4) containing 5% DMSO.  
We also investigated the ability for HNOCL-1 to detect HNO in vivo. We conducted the 
experiments in the BALB/c nude mice. From the results, the chemiluminescence emission from 
the experimental group with 1 mM AS and 40 µM HNOCL-1 increase 300-fold compared with 
the vehicle control. This result shows that HNOCL-1 has promise for pharmacological HNO 
detection in vivo.  
3.3 Conclusions 
In summary, we have described the first chemiluminescent probe for real-time monitoring 
of HNO in living cells. The rapid and sensitive response has enabled an innovative kinetics-based 
approach that provides quantitative estimates of HNO concentration. To date, this has only been 
accomplished using electrodes and a xerogel optical sensor film, which are inherently limited to 
extracellular monitoring. Chemiluminescent probes like HNOCL-1 can be loaded into cells, and 
we anticipate that expansion of this kinetics-based approach will lead to a unique method for 
quantification of HNO in living cells. This approach is generalizable to other reaction-based probes 
as long as one can achieve high sensitivity, mechanistic understanding, and evaluation of kinetic 
parameters. The cellular data shows that HNOCL-1 provides a method to reliably monitor the 
time-course of HNO delivery from donor systems and preliminary experiments in living mice 
demonstrate that the high photon flux from HNOCL-1 is sufficient for imaging HNO in animal 
tissue. We anticipate that HNOCL-1 will find use in understanding HNO biology and the 




3.4 Experimental Methods 
3.4.1 General synthetic materials and methods.  
All reactions were performed in dried glassware under an atmosphere of dry N2. Silica gel 
P60 (SiliCycle) was used for column chromatography and Analytical Chromatography TLC Silica 
gel 60 F254 (Merck Millipore, Darmstadt, Germany) was used for analytical thin layer 
chromatography. Plates were visualized by fluorescence quenching under UV light or by staining 
with iodine. N,N-Diisopropylethylamine was distilled from potassium hydroxide, but all other 
reagents were used without further purification. Anhydrous dimethylformamide was used in all 
reactions. Other reagents were purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward 
Hill, MA), EMD Millipore (Billerica, MA), Oakwood Chemical (West Columbia, SC), or TCI 
(Tokyo, Japan) and used without further purification. 1H NMR and 13C NMR spectra for 
characterization of new compounds and monitoring reactions were collected in CDCl3 (Cambridge 
Isotope Laboratories, Cambridge, MA) on a JEOL 500 MHz spectrometer in the Department of 
Chemistry at Southern Methodist University. All chemical shifts are reported in the standard 
notation of parts per million using the peak of residual proton signals of the deuterated solvent as 
an internal reference. Coupling constant units are in Hertz (Hz) Splitting patterns are indicated as 
follows: br, broad; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublets; 
dt, doublet of triplets. Chemical abbreviations are used as follows: CH2Cl2, dichloromethane; 
EtOAc, ethyl acetate; THF, tetrahydrofuran; DMF, dimethylformamide; H2O, water; HBTU, O-
benzotriazole-N,N,N’,N’-tetramethyl- uronium-hexafluoro- phosphate; DIPEA, N,N-
diisopropylethylamine; KOH, potassium hydroxide; DMSO, dimethylsulfoxide N2, nitrogen. High 
resolution mass spectroscopy was performed on a Shimadzu IT-TOF (ESI source) and low 
resolution mass spectroscopy was performed on a Shimadzu LCMS-8050 Triple Quadrupole 
LCMS (ESI source) or a Shimadzu Matrix Assisted Laser Desorption/Ionization MS (MALDI) at 





(12). 2-Chloro-3-methoxybenzaldehyde (9900 mg, 58.6 mmol, 1 equiv) was dissolved with 80 mL 
MeOH in a dry flask filled with N2. Trimethyl orthoformate (6.4 mL, 59 mmol, 1.0 equiv) and p-
Toluenesulfonic acid (1009 mg, 5.9 mmol, 0.1 equiv) was added to the flask. The mixture was 
stirred for 24 hours at room temperature under N2. After that the mixture was neutralized by NEt3. 
300 mL NaHCO3 was poured into the mixture and extract with 3 x 300 mL EtOAc. The organic 
layer was dried by Na2SO4, filtered and concentrated under reduced pressure to obtain crude acetal 
11 (1897 mg). Compound 11 was dissolved in 20 mL DCM at 0 °C. Triethyl phosphite (10.5 mL, 
61.1 mmol, 1.0 equiv) and boron trifluoride etherate (7.7 mL, 61.1 mmol, 1.0 equiv) were added 
to the flask at 0 °C and stir for 20 mins. The reaction was raised to 30 °C and stirred for 2 hours. 
The reaction was quenched by 50 mL NaHCO3, extracted by 3 x 50 mL EtOAc and dried by 
Na2SO4 and filtered. The EtOAc was evaporated under reduced pressure and purified by column 
chromatography (1:15 EtOAc/Hexane) yield the product as a pale yellow oil 12 (1339 mg, >95 %). 
1H NMR (500 MHz, CDCl3) d 7.29 (m, 2H), 6.91 (m, 1H), 5.19 (d, 1H, J = 15.0 Hz), 4.17–4.21 
(m, 4H), 4.16 (s, 3H), 3.34 (s, 1H), 1.31–1.35 (t, 3H, J = 6.8 Hz), 1.19–1.24 (t, 3H, J = 6.8 Hz); 
13C NMR (125 MHz, CDCl3) d 156.41, 135.67, 128.82, 124.33, 122.63, 113.16, 77.04, 64.66, 
64.57, 60.26, 57.73, 17.91, 17.80. 
 
 
 (13). Compound 12 (19351 mg, 60 mmol, 1.0 equiv) was dissolved in 30 mL anhydrous THF in 
a dry flask under N2 and cooled to –78°C by adding dry ice to acetone. 2-Adamantanone (11174 
mg, 72.0 mmol, 1.2 equiv) was dissolved in 30 mL anhydrous THF and cooled to –78 °C. 30.0 mL 
1.6 M n-BuLi was added to the compound 12 solvent at –78 °C and stirred for 20 min. The cooled 
2-adamantanone solution was added to the flask and the temperature of the reactants was raised to 
30 °C. The mixture was stirred for 2 hours and the temperature was raised to 90 °C under reflux. 
After 1 hour reflux, the reaction was quenched by 100 mL NH4Cl and extracted by 3 x 100 mL 













oil (17320 mg, 91%). 1H NMR (400 MHz, CDCl3) d 7.25 (t, 1H, J = 7.6 Hz), 6.89–6.94 (m, 2H), 
3.95 (s, 3H), 3.34 (s, 3H), 3.32 (s, 1H), 1.62–2.10 (m, 12H); 13C NMR (125 MHz, CDCl3) d 155.28, 
139.91, 136.12, 131.17, 126.80, 124.09, 123.16, 111.24, 57.05, 56.27, 47.06, 39.35, 38.71, 37.24, 
37.06, 34.68, 33.07, 32.91, 29.67. 
 
 
 (14). Compound 13 (4662 mg, 14.6 mmol, 1.0 equiv) was dissolved in 35.0 mL anhydrous DMF 
at room temperature in a dry flask under N2. Cs2CO3 (5781 mg, 17.6 mmol, 1.2 equiv) and EtSNa 
(1496 mg, 17.6 mmol, 1.2 equiv) was added to the flask. The temperature of the mixture was raised 
to 90 °C under reflux for 18 hours. The reaction was quenched by 200 mL of NH4Cl, extracted by 
3 x 200 mL. The mixture was washed with 3 x 200 mL brine to remove the extra DMF and the 
organic layer was dried over Na2SO4 and evaporated under reduced pressure. Purification by 
column chromatography (1:19 EtOAc:Hexane) yielded compound 14 as a white solid (3657 mg, 
82%). 1H NMR (500 MHz, CDCl3) d 7.14 (t, 1H, J = 8 Hz), 6.98 (dd, 1H, J1 = 10.0 Hz, J2 = 2.5 
Hz), 6.82 (dd, 1H, J1 = 7.5 Hz, J2 = 1.15 Hz), 3.30 (s, 3H), 3.27 (s, 1H), 1.70–1.93 (m, 12H); 13C 
NMR (125 MHz, CDCl3) d 151.79, 139.79, 135.06, 131.91, 127.38, 123.96, 120.64, 115.54, 57.16, 
47.04, 39.35, 38.71, 37.18, 36.37, 34.61, 33.24, 32.89, 29.72. 
 
 
(15). Compound 14 (4584 mg, 15.0 mmol, 1 equiv) was dissolved with 70 mL toluene at –5 °C. 
The NIS (3391 mg, 15.0 mmol, 1 equiv) was added to the solvent later and the mixture was stirred 
at 0 °C for 50 mins. The mixture was washed with 100 mL brine to quench the reaction and extract 
with 3 x 200 mL EtOAc. Several pieces of Na2S2O3 crystals were added to the mixture to remove 
the extra iodine. The color of the mixture was changing during the work-up. It turned from red to 
brown, later to orange and finally the organic layer ended up with light yellow. The organic layer 
was later dried trough Na2SO4 and the solvent was removed under reduced pressure. A pale dark 











after wash (3818 mg, 59%). 1H NMR (500 MHz, CDCl3) d 7.60 (d, 1H, J = 8 Hz), 6.09 (d, 1H, J 
= 8.0 Hz), 3.30 (s, 3H), 3.25 (s, 1H), 2.08 (s, 1H), 1.72–1.94 (m, 12H); 13C NMR (125 MHz, 
CDCl3) d 177.03, 151.19, 144.48, 139.23, 136.78, 135.77, 132.69, 130.38, 127.38, 125.28, 120.07, 
99.03, 82.23, 57.31, 37.11, 32.93, 29.66, 28.40. 
 
(16). Compound 15 (300 mg, 0.7 mmol, 1 equiv), and Pd(OAc)2 (7.8 mg, 0.04 mmol, 0.05 equiv) 
was added to the microwave reaction tube and fill the tube with N2. Dessolve the mixture with 1.0 
mL MeCN. Later TEA (0.15 mL, 1.0 mmol, 1.5 equiv) was added to the tube and all the solid was 
dissolving upon the addition. Acrylonitrile (0.14 mL, 2.1 mmol, 3 equiv) was added to the mixture 
later. The tube was put into the microwave and set the temperature to 120 °C for 70 mins. When 
the reactants cooled down to the room temperature, add 30 mL saturated NH4Cl to it. The 3 x 30 
mL EtOAc was added to the mixture to extract the product. The organic layer was later dried 
through Na2SO4 and the solvent was removed under reduced pressure. A brown oil was obtained 
after the evaporation. Purification of the product is through the column chromatography with pure 
DCM and a light yellow sold was obtained. (101 mg, 41%). 1H NMR (400 MHz, CDCl3), d 7.60 
(d, 1H, J = 16 Hz), 7.30 (d, 1H, J = 8 Hz), 6.91 (d, 1H, J = 4 Hz), 6.38 (s, 1H), 6.20 (s, 1H, 1H, J 
= 16 Hz), 3.33 (s, 3H), 3.29 (s, 1H), 2.12 (s, 1H), 1.98–1.78 (m, 12H); 13C NMR (125 MHz, CDCl3) 
d 150.45, 145.26, 139.08, 137.43, 133.36, 126.71, 123.74, 120.96, 118.51, 98.59, 57.38, 39.15, 
39.01, 38.84, 38.71, 38.57, 36.93, 32.87, 29.69, 28.19. 
 
 
(17). Compound 16 (101 mg, 0.3 mmol, 1.0 equiv) and Rose Bengal (22.2 mg, 0.02 mmol, 0.07 
equiv) were added into a dry two-neck flask and dissolved in 5 mL THF. O2 was bubbled through 
the solvent while illuminated with a 120W light bulb (Home Depot, Dallas, TX) at 0–5°C. Monitor 
the reaction by TLC. After 1 hour, the mixture was concentrated at 0 °C. Purification by silica 
column chromatography (1:19 EtOAc/Hexane) delivered compound 17 as a light yellow solid 













7.45 (d, 1H, J = 4 Hz), 6.59 (s, 1H), 6.26 (d, 1H, J = 16 Hz), 3.24 (s, 3H), 3.04 (s, 1H), 2.05 (s, 
1H), 1.89–1.59 (m, 12H). 13C NMR (125 MHz, CDCl3) d. 150.69, 144.77, 134.74, 126.82, 124.84, 




[1,2]dioxetan]-4'-yl)phenyl 2-(diphenylphosphaneyl)benzoate (HNOCL-1). The compound 2-
(diphenylphosphino) benzoic acid (12.4 mg, 0.039 mmol, 1 equiv) was added to a dry, N2 filled 
flask and dissolved with 5.0 mL CH2Cl2. Dimethylaminopyridine (6.0 mg, 0.048 mmol, 1.25 equiv) 
and N-(3-dimethylaminopropyl)-N'-ethylcarbodimiide hydrochloride (8.0 mg, 0.039 mmol, 1.0 
equiv) were added to the flask. The mixture was stirred at room temperature for 5 min. The 
compound 17 (15.0 mg, 0.039 mmol, 1.0 equiv) was dissolved in 2.0 mL CH2Cl2 and added to the 
mixture. The reaction was stirred at ambient temperature for 2 hr. The reaction was quenched by 
30 mL saturated NH4Cl and extracted with 3 x 30 mL CH2Cl2. The organic layer was dried with 
Na2SO4, filtered and concentrated. Purification by silica column chromatography (10:1 
Hexane:EtOAc) yielded HNOCL-1 (12.9 mg, 49%) as a white solid. 1H NMR (500 MHz, CDCl3) 
δ 8.39–8.38 (m, 1H),) 7.94 (d, 1H, J = 8.5 Hz), 7.46–7.44 (m, 4H), 7.28–7.18 (m, 10H), 6.96–6.95 
(m, 1H), 5.85 (d, 1H, J = 17.1 Hz), 3.06 (s, 3H), 2.91 (s, 1H), 1.85–1.35 (m, 13H); 13C NMR (125 
MHz, CDCl3δ 146.48, 143.08, 137.04, 136.96, 136.00, 134.54, 134.23, 134.05, 133.98, 133.91, 
133.82, 133.66, 133.51, 132.10, 130.63, 130.04, 129.02, 128.64, 128.59, 128.46, 127.33, 124.09, 
117.29, 111.39, 100.86, 96.36, 49.80, 39.22, 36.49, 33.80, 33.54, 32.09, 31.54, 31.47, 30.92, 26.08, 


















Ethyl 2-((3'-hydroxy-3-oxo-3H-spiro [isobenzofuran-1,9'-xanthen]-6'-yl)oxy)acetate (3). 
Fluorescein (600 mg, 1.81 mmol, 1.0 equiv) was dissolved in 5 mL of DMF. DIPEA (0.94 mL, 
5.4 mmol, 3.0 equiv) was added and the reaction mixture was stirred for five minutes. Ethyl 
bromoacetate (0.40 mL, 3.6 mmol, 2.0 equiv) was added. The reaction was stirred at rt for 5 h. 
The reaction mixture was poured into a separatory funnel containing 100 mL of CH2Cl2, washed 
with 85 mL H2O and 40 mL of brine. The organic layer was dried over sodium sulfate, filtered, 
and concentrated. The resulting product was purified by silica gel column chromatography (1:1 
Hexanes:EtOAc) to afford the ethyl acetate fluorescein 3 (182 mg, 24% yield). 1H NMR (500 MHz, 
CDCl3) d 8.03 (d, 1H, J = 6.3 Hz), 7.67 (td, 1H, J = 6.3, 1.2 Hz), 7.62 (t, 1H, J = 7.4 Hz), 7.16 (d, 
1H, J = 7.4 Hz), 6.75–6.25 (m, 5H), 6.53 (dd, 1H, J = 8.6, 2.9 Hz), 5.21 (s, 1H), 4.65 (s, 2H), 4.29 
(q, 2H, J = 6.8 Hz), 1.31 (t, 3H, J = 6.7 Hz); 13C NMR (125 MHz, CDCl3) d 169.95, 168.61, 159.47, 
157.97, 153.17, 152.47, 135.24, 129.86, 129.43, 126.76, 125.13, 124.01, 112.47, 112.37, 111.77, 









































3'- (2 - Ethoxy - 2 - oxoethoxy) - 3 - oxo - 3H - spiro[isobenzofuran - 1,9' - xanthen] - 6' - yl 2-
(diphenylphosphanyl) benzoate (XF2). 2-(diphenylphosphino)benzoic acid (74.7 mg, 0.244 
mmol, 1.0 equiv) and HBTU (111 mg, 0.293 mmol, 1.2 equiv) were dissolved in 5 mL of DMF. 
DIPEA (0.190 mL, 1.01 mmol, 4.1 equiv) was added and the reaction was stirred for 5 min. 
Compound 3 (99.3 mg, 0.243 mmol, 1.0 equiv) was added and the reaction was stirred at rt for 2.5 
h. The reaction mixture was poured into a separatory funnel containing 50 mL of CH2Cl2, washed 
with 3 x 50 mL H2O and 50 mL of brine. The organic layer was dried over sodium sulfate, filtered, 
and concentrated. The resulting product was purified by silica gel column chromatography (3:2 
Hexanes:EtOAc) to afford XF2 (37.3 mg, 29% yield) as a clear oil. 1H NMR (500 MHz, CDCl3) 
d 8.26–824 (m, 1H), 8.02 (d, 1H, J = 7.5 Hz), 7.67 (td, 1H, J = 7.5, 1.2 Hz), 7.62 (t, 1H, J = 7.5 
Hz), 7.48–7.36 (m, 2H), 7.37–7.26 (m, 10H), 7.14 (d, 1H, J = 7.4 Hz), 7.01–6.98 (m, 1H), 6.96 (d, 
1H, J = 2.3 Hz), 6.76–6.61 (m, 5H), 4.64 (s, 2H), 4.29 (q, 2H, J = 6.9 Hz), 1.31 (t, 3H, J = 6.9 Hz); 
13C NMR (125 MHz, CDCl3) d 169.28, 168.30, 164.70, 159.49, 152.95, 152.12, 151.77 151.64, 
141.70, 141.47, 137.44, 137.36, 135.15, 134.49, 134.08, 133.90, 133.02, 132.76, 131.40, 129.87, 
129.27, 128.89, 128.84, 128.61, 128.55, 128.35, 126.34, 125.08, 124.06, 117.60, 116.57, 112.02, 
110.47, 101.90, 82.23, 65.42, 61.61, 14.16; HRMS calcd for C43H31O8P [M+H]+ 707.1829, found 
707.1831. 
 
3.4.2 Chemiluminescence response of HNOCL-1.  
Chemiluminescence responses and time scans were acquired with a Hitachi F-7000 Fluorescence 
Spectrophotometer (Hitachi, Tokyo, Japan, Figures 3-1 A, 3-1, 3-3 B) using the luminescence 
detection module or a Cytation 5 BioTek plate reader (Winooski, VT, Figures 3-1 B, 3-3 A, 3-4 
A, 3-6 A, 3-7 A) using the luminescence detection method, endpoint read type, and setting gain to 
135 and operating at ambient temperature (25–28 ºC). 20 mM PBS buffer (pH 7.4), 5 mM 
HNOCL-1 stock solution in DMSO (20 µM final concentration) and Angeli’s salt were added to 










gently to assure mixing. For spectral scans, 20 μM HNOCL-1 was treated with 0, 50, 100, 150 
and 200 μM Angeli’s salt and measured in a fluorescence spectrometer. Time scans were acquired 
using the plate reader with 0, 5, 25, 50, and 100 µM Angeli’s salt. The time between adding 
Angeli's salt and beginning the measurement was recorded and was between 20 and 100 seconds.  
 
3.4.3 GC/MS determination of HNOCL-1 products.  
A 5.1 mM stock solution of Angeli’s salt was made by dissolving Angeli’s salt in 0.01 mM NaOH, 
and the final concentration was confirmed by UV/Vis by measuring the absorbance at 237 nm (e 
= 6100 M–1 cm–1). 1.3 mg (0.0019 mmol) of HNOCL-1 was dissolved in 10.0 mL acetone in a 20 
dram vial.  9.62 mL of 20 mM PBS buffer (pH = 7.4) and 0.38 mL of 5.1 mM Angeli’s salt solution 
were added to make a final concentration of 95 µM HNOCL-1 with 95 µM Angeli’s salt. A stir 
bar was added, and the solution was capped and stirred at room temperature for 24 hours.  The 
solution was poured into a separatory funnel, washed with brine, and the organic layer was 
extracted with 3 x 15 mL EtOAc. The organic layer was evaporated under reduced pressure, and 
the leftover contents were dissolved in 1.5 mL CH2Cl2 and pipetted into a GC/MS vial. GC/MS 
was conducted immediately using a 6850 Series GC/MS (Agilent Technologies, Santa Clara, CA). 
Mass spectra were averaged across the major peaks in the chromatogram and molecular ions for 
m/z = 150.1 (Figure 3-9) and m/z = 304.1 (Figure 3-10) were found. The spectrum of 2-
adamantanone was matched against the NIST standard, which can be found via web at: 
 https://webbook.nist.gov/cgi/cbook.cgi?ID=C700583&Units=CAL&Mask=200#Mass-Spec, 










Figure 3- 10. Mass spectrum of the peak assigned to the acyl iminophosphorane. 
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3.4.4 Solubility and stability studies.  
Solutions of 20, 40, 60, 80, and 100 µM HNOCL-1 were prepared in 20 mM PBS (pH = 7.4) 
containing 1% DMSO. The precipitation was evaluated by measuring the raise in the baseline 
absorbance at 750 nm (Figure 3-11). In order to evaluate stability, 20 µM HNOCL-1 was pre-
incubated in 20 mM PBS (pH 7.4) containing ≤ 1% DMSO for 0, 60, or 120 minutes before treating 
with 200 µM Angeli's salt. The time-course of the chemiluminescence emission was measured 
using a Cytation 5 BioTek plate reader (Figure 3-12). 
 
 
Figure 3- 11. Solubility of HNOCL-1. (A) Photographs of cuvettes containing 20, 60, and 100 
µM HNOCL-1 in 20 mM PBS buffer containing ≤ 1% DMSO. (B) Absorbance at 750 nm of 20–
100 µM HNOCL-1 in 20 mM PBS buffer containing ≤ 1% DMSO. Error bars are ± S.D. from n 
= 3 replicates. 
 
Figure 3- 12. Stability of HNOCL-1. 20 µM HNOCL-1 was pre-incubated in 20 mM PBS (pH 
7.4) containing ≤ 1% DMSO for 0 (blue trace), 60 (black trace), or 120 (red trace) minutes before 
treating with 200 µM Angeli's salt. Error bars are ± S.D. from n = 3 replicates 
 
3.4.5 Determination of the detection limit for HNOCL-1  
Chemiluminescence responses were measured using a Cytation 5 BioTek plate reader (Winooski, 






































temperature to 30 °C. A 0.3016 mM stock solution of Angeli’s salt was made by dissolving 
Angeli’s salt with 0.01 mM NaOH, and the final concentration was confirmed by UV/Vis by 
measuring the absorbance at 237 nm (e = 6100 M–1 cm–1). An aliquot of 1 µL of a 5 mM HNOCL-
1 stock solution (final concentration of 20 µM) was added to each well, filled with the appropriate 
volume of 20 mM PBS buffer for a final volume of 250 µL in each well. Finally, Angeli's salt was 
added to each well to give final concentrations of 0, 0.25, 0.5, 1, 1.5, and 2 µM Angeli's salt. The 
emission was integrated over 20 minutes and the calibration curve was constructed using 
experiments replicated on two different days, for a total of 6 replicates for each data point (3 
replicates for 0.25 and 2 µM). The detection limit (3s/k) was determined as 138 nM, which, 




Figure 3- 13. Determination of detection limit. (A) Chemiluminescence emission intensity of 20 
µM HNOCL-1 and 0 (blue trace), 0.25, 0.5, 1, 1.5, and 2 µM (red trace) Angeli's salt. (B) 
Calibration plot of integrated emission intensity versus [AS]. Error bars are ± S.D. from n = 3–6 
replicates. 
 































































































Figure 3- 14. (A) Fluorescence response of 10 µM XF2 to 200 µM Angelis' salt. Time points 
represent 0, 1, 5, 10, 15, 20, and 25 min after addition of 200 µM Angeli's salt. (B) Fluorescence 
response of 10 µM XF2 to 200 µM biologically relevant reactive oxygen and nitrogen species. 
Emission was collected from 508 and 650 nm. Legend: (1) AS; (2) H2S; (3) ONOO–; (4) NaOCl; 
(5) H2O2; (6) GSH (5 mM); (7) GSNO; (8) DEA NONOate; (9) tBuOOH. Data were acquired in 
20 mM HEPES buffer (pH 7.4) at 21 °C with excitation at lex = 488 nm. Bars represent fluorescent 
emission at 508 nm, and 1, 5, 10, 15, 20, 25, and 30 minutes after addition of the analyte. Error 
bars are ± S.D. from n = 3 replicates. 
 
Selectivity for XF2 was performed using an F-7000 fluorescence spectrophotometer (Hitachi, 
Tokyo, Japan) and monitored every 5 minutes for 30 minutes. UV/Vis measurements were 
acquired on a DU-800 spectrophotometer (Beckman Coulter, Brea, CA). Reactions were 
performed as triplicates. All probe aliquots were prepared as 5 mM stock solutions in DMF and 
the selectivity reactions were performed in 20 mM HEPES (pH 7.4). 
 
Blank: 2 μL of 5 mM XF2 was added to 998 μL of 20 mM HEPES (10 µM final concentration).  
 
AS: 2 μL of 5 mM or XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration), 
and 20 μL of 10 mM AS (confirmed by UV-Vis) was added to the mixture (200 µM final 
concentration).  
 
H2S: 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration), and 
20 μL of 10 mM Na2S in H2O was added to the mixture (200 µM final concentration).  
 
NaOCl: 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration), 
and 20 μL of 10 mM NaOCl in H2O was added to the mixture (200 µM final concentration). 
 
H2O2: 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration), 
and 20 μL of 10 mM H2O2 was added to the mixture (200 µM final concentration). 
 
Glutathione: 2 μL of 5 mM XF2 was added to 898 μL of 20 mM HEPES (10 µM final 
concentration), and 100 μL of 50 mM glutathione was added to the mixture to make final 
concentration of 5 mM for glutathione. 
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S-nitrosoglutathione: S-nitrosoglutathione (GSNO) was synthesized and characterized using a 
literature procedure.48 Approximately 1 mg of GSNO was dissolved in 1 mL DI H2O, and the 
precise concentration was measured by UV/Vis using the absorptions at 335 nm (ε = 922 M-1 cm-
1) or 545 nm (ε = 15.9 M-1 cm-1). The solution was made on a daily basis and kept at 0 oC. 2 μL of 
5 mM XF2 was added to 982.1 μL of 20 mM HEPES (10 µM final concentration), and 15.9 μL of 
12.58 mM S-nitrosoglutathione was added to the mixture (200 µM final concentration).  
 
ONOO–: ONOO– was synthesized based on an adaptation of a literature procedure,49 by adding 
0.24 mL of H2O2 (35% wt. in H2O, 2.8 mmol, 1.4 equiv) to a round bottom flask containing 4.5 
mL of 0.55 M NaOH and 5 mL isopropyl alcohol. Isoamyl nitrite (0.27 mL, 2.0 mmol, 1.0 equiv) 
was added, and stirred at rt for 15 minutes. MnO2 (10 mg, 0.12 mmol) was added to the reaction 
and stirred for extra 5 minutes to decompose excess H2O2. The reaction mixture was filtered to 
remove MnO2 and washed four times with 10 mL of DCM in a separatory funnel. The aqueous 
layer was removed with a Pasteur pipet to avoid having any DCM. The concentration was 
determined by UV/Vis using the absorption at 302 nm (ε = 1670 M-1 cm-1), and was diluted to 
make a 10 mM stock solution. 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM 
final concentration), and 20 μL of 10 mM ONOO– was added to the mixture (200 µM final 
concentration).  
 
DEA NONOate: A stock solution of DEA NONOate (Cayman Chemical, Ann Arbor, Michigan) 
was prepared in 0.01 M NaOH and the precise concentration was measure by UV/Vis using the 
absorption at 250 nm (ε = 6500 M-1 cm-1), and diluted to a final concentration of 10 mM. 2 μL of 
5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration), and 20 μL of 10 
mM DEA NONOate was added to the mixture (200 µM final concentration).  
 
tBuOOH: 2 μL of 5 mM XF2 was added to 978 μL of 20 mM HEPES (10 µM final concentration), 




General methods. Chemiluminescent responses were measured using a Cytation 5 BioTek plate 
reader (Winooski, VT) using the luminescence detection mode, end point read type. Measurements 
were made at ambient temperature (25–28 °C), the gain was set at 135, and the height was set at 
4.5 mm.  
 
 
Derivation of equation (1). The reactions between HNOCL-1 and HNO used to model triggered 
chemiluminescence are shown in Scheme 3-8 and the derivation of equation (1) is given in 
reactions (2) – (4) and equations (5) – (12). 
 























































[1] hn + products
k3
d[HNO]/dt = –k1[HNOCL-1][HNO]
d[2]/dt = k1[HNOCL-1][HNO] – k2[2]
d[1]/dt = k2[2] – k3[1]
[HNO] = 1/(k1[HNOCL-1]) (k2[2] + d[2]/dt) 
[2] = 1/k2 (k3[1] + d[1]/dt)
d[2]/dt = 1/k2 (k3d[1]/dt + d2[1]/dt2)







The reaction between the triaryl phosphine in HNOCL-1 and HNO forms an azaylide intermediate 
2 in reaction (2) with a rate defined by equation (6). While it takes two equivalents of probe to 
form product, we use an observed second order rate constant, k1, determined as described below. 
Since the concentration of probe is constant throughout all experiments in this manuscript, the 
observed second order rate constant will be consistent with this model. The nucleophilic nitrogen 
of 2 mediates ester cleavage to form the phenol 1 in the intramolecular reaction (3) with a rate 
defined by equation (7). Finally, 1 decomposes via a chemically initiated electron exchange 
luminescence (CIEEL) mechanism in reaction (4) with a rate also defined by equation (7). 
Equation (6) can be reorganized into equation (8) to provide [HNO] in terms of [2] and d[2]/dt and 
equation (7) can be reorganized into equation (9) to provide [2] in terms of [1] and d[1]/dt, which 
is differentiated to give equation (10). Substitution of equations (9) and (10) into equation (8) 
provides equation (11), which can be reorganized into equation (12). Here, we make two key 
assumptions:  
1. If k3 << k2 (this is true if the chemiluminescent decomposition is rate-limiting) and the second 
derivative d2[1]/dt2 is small, then equation (12) simplifies to equation (1). 
2. [HNOCL-1] >> [HNO], and so [HNOCL-1] can be approximated as constant over the course 
of the reaction.  
In order to use equation (1) to obtain [HNO] from the relative chemiluminescent emission we need 
to know k1, k3, [1], and d[1]/dt.  
 
Measurement of k1. The value of k1 was measured by a method similar to that of Miranda and 
Wink5 by looking at the chemiluminescence response of HNOCL-1 with increasing 
concentrations of Angeli's salt. Due to instrumental limitations, experiments were performed under 
aerobic conditions, so the relevant rate is defined by equation (13), where kD is the rate of HNO 
dimerization, k1 is the rate of reaction of the probe with HNO, kO2 is the rate of reaction of O2 with 
HNO, and kAS is the rate of the decomposition of Angeli's salt (AS). 
 
(13) 
[HNO] = 1/(k1[HNOCL-1]) (k3[1] + (1+ k3/k2) d[1]/dt + (1/k2) d2[1]/dt2) 
[HNO] = 1/(k1[HNOCL-1]) (k3[1] + d[1]/dt) 
d[HNO]/dt = –2kD[HNO]2 – k1[HNOCL-1][HNO] – kO2[O2][HNO] + kAS[AS] 
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Using the steady state approximation and applying the quadratic equation gives: 
 
(14) 
As the concentration of Angeli's salt is increased, dimerization is the main competitive reaction. 
At the concentration of Angeli's salt that gives 50% product formation versus competitive HNO 
dimerization, the rates are equal and equation (15) holds as derived by Miranda and Wink.5 
 
(15) 
Substitution into equation (14) gives equation (16), which simplifies (after reorganization and 





The concentration of Angeli's salt needed for 50% product formation was found to be 0.148 mM 
from the experiment shown in Figure 3-15.  
 
Figure 3- 15. Initial value of the relative emission intensity of 20 µM HNOCL-1 and 0, 0.2, 0.5, 
1, 2, and 4 mM Angeli's salt in pH 7.4 PBS buffer at 25 ºC. Error bars are ± S.D. from n = 3 
replicates. 
 
Other values were used as reported in the literature: 
kO2 = 18,000 M–1s–1 at 25 ºC50 
[O2] = 225 µM50 
kAS  = 0.00084 s–1 at 25 ºC50 
kD = 8,000,000 M–1s–1 at 23 ºC51 
[HNO] =  (k1[HNOCL-1] + kO2[O2]) ± ((k1[HNOCL-1] + kO2[O2])2 – 4(–2kD)kAS[AS])1/2
2*(–2kD)
k1 = –2kD [HNO]/[HNOCL-1]
k1 =       2kD               *   (k1[HNOCL-1] + kO2[O2]) ± ((k1[HNOCL-1] + kO2[O2])2 – 4(–2kD)kAS[AS])1/2
2*(–2kD)[HNOCL-1]























[HNOCL-1] = 20 µM 




Measurement of k3 and calibration of [1]. The rate of chemiluminescent decomposition, k3, was 
determined from monitoring the chemiluminescence emission of isolated 1 over time to yield a 
value of k3 = 5.92 ± 0.32 x 10–4 s–1 at 25 ºC and pH 7.4 (Figure 3-16, A). The rate was independent 
of the concentration of 1, and this reported value is the average of the value determined at different 
concentrations of 1. Plotting the initial value of the chemiluminescence emission versus the 
concentration of 1 provided a linear calibration plot to convert the relative emission intensity into 
[1]. The calibration was performed on four separate days and the average values were used to 
construct the plot in Figure 3-16, B. 
 
 
Figure 3- 16. (A) Time course of the chemiluminescence emission of 0 (blue trace), 0.5, 1, 1.5, 2, 
2.5, and 3 µM (red trace) 1. (B) Calibration plot of the initial chemiluminescence emission 
intensity versus concentration of 1. Error bars are ± S.D. from n = 4 replicates. 
 
Example of converting relative chemiluminescence emission into [HNO]. The raw 
chemiluminescence emission (Figure 3-17, A) was converted into a plot of [1] using the linear 
calibration plot in Figure 3-16, B, and the derivative at each point was determined by computing 
the slope (Figure 3-17, C). In order to reduce noise, [1] was averaged over 30 seconds (2 data 
points). The concentration of [HNO] was determined using equation (1) and is represented by the 
black data points in Figure 3-17, D. The simulation was computed by numerical solution of 
equation (20), derived from equation (13), and is given as the red trace in Figure 3-17, D. 













































































































































The rate of decomposition of Angeli's salt follows equation (18), which can be solved analytically 
to provide equation (19), where [AS]0 is the initial concentration of Angeli's salt. Substitution into 
equation (13) provides equation (20), which was solved numerically using Wolfram Mathematica 









Figure 3- 17. Quantification of HNO concentration. (A) Time-course of the chemiluminescence 
emission intensity of 20 µM HNOCL-1 and 50 µM Angeli's salt. (B) Conversion from relative 
emission intensity to [1] using the calibration curve in Figure 3-16, B. (C) Time-course of the 
derivative determined from the plot in Figure 3-17, B. (D) HNO concentration measured using 
equation 1 (black data points) and simulated by numerically solving equation 20 (red trace). 
 
3.4.8 Selectivity tests for HNOCL-1 
Selectivity for HNOCL-1 was measured by monitoring the time-dependent chemiluminescent 
emission at 525 nm with an F-7000 fluorescence spectrophotometer (Hitachi, Tokyo, Japan). All 
assays were performed in 20 mM HEPES buffered to pH 7.4, except for HO•, which was performed 
in 20 mM PBS buffered to pH 7.4. All analytes were tested with final concentration of 200 μM, 
d[HNO]/dt = –2kD[HNO]2 – k1[HNOCL-1][HNO] – kO2[O2][HNO] + kAS[AS] 
d[AS]/dt = –kAS[AS] 
[AS] = [AS]0e–k tAS

















































































































































with the exception of glutathione (2 mM) and L-cysteine (1 mM).  
 
HNO (200 µM): Angeli’s salt (Na2N2O3) was used to generate HNO. The stock solution was made 
by dissolving Angeli’s salt in 0.01 M NaOH solution immediately prior to use. The concentration 
of this alkaline stock solution of Angeli's salt was measured by UV/Vis is using e = 6100 M–1 cm–
1 at 237 nm. 13.6 μL of a 14.7 mM stock solution of Angeli's salt in 0.01 M NaOH was added to a 
986 μL solution of 20 μM HNOCL-1 (from 4 µL of a 5 mM stock solution) in HEPES buffer. 
 
ONOO– (200 µM): 7 μL of 28.5 mM ONOO– was added to a solution of 989 μL HEPES buffer 
and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO.  
 
NO2– (200 µM): 4 μL of 50 mM NaNO2 in DI-H2O was added to a solution of 992 μL HEPES 
buffer and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO.  
 
L-Cysteine (1 mM): 10 µL of 100 mM L-cysteine and 4 µL of 5 mM HNOCL-1 (20 µM final 
concentration) in DMSO were added to 986 µL HEPES buffer. 
 
GSNO (200 µM): 4 μL of 50 mM GSNO in DI-H2O was added to a solution of 992 μL HEPES 
buffer and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO. 
 
GSH (2 mM): 20 μL of 100 mM GSH in DI-H2O was added to a solution of 976 μL HEPES buffer 
and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO. 
 
H2O2 (200 µM): 4 μL of 50 mM H2O2 in DI-H2O was added to a solution of 992 μL HEPES buffer 
and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO. 
 
tBuOOH (200 µM): 4 μL of 50 mM tBuOOH in DI-H2O was added to a solution of 992 μL HEPES 
buffer and 4 μL of 5 mM HNOCL-1 (20 µM final concentration) in DMSO. 
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O2•– (200 µM): 280 µL of 5 mM HNOCL-1 stock solution (20 µM final concentration) in DMSO 
was added to 70 mL HEPES buffer, later 1.0 mg KO2 (200 µM final concentration) was added to 
the mixture. 
 
Na2S (200 µM): 4 μL of 50 mM Na2S in DI-H2O was added to a solution of 992 μL HEPES buffer 
and 4 μL of 5 mM HNOCL-1 in DMSO (20 µM final concentration). 
 
HO• (200 µM): 4 µL of 5 mM HNOCL-1 stock solution was added to 988 µL 20 mM PBS buffer 
(pH = 7.4). Later 4 µL 50 mM Fe(ClO4)2 and 4 µL of 50 mM H2O2 were added to the mixture. 
 
NO (200 µM): DEA NONOate was used to generate NO. It was stored at –20 °C and dissolved in 
0.01 M NaOH solution immediately prior to use. The concentration of this alkaline stock solution 
of DEA NONOate was measured by UV/Vis using e = 6500 M–1 cm–1 at 250 nm. 2.51 μL of 79.7 
mM DEA NONOate in 0.01 M NaOH solution was added to a 993 μL solution of 20 μM HNOCL-
1 in HEPES buffer.  
 
OCl– (200 μM): 4 μL of 50 mM NaOCl in DI-H2O was added to a solution of 992 μL HEPES and 
4 μL of 5 mM HNOCL-1 in DMSO (20 µM final concentration). 
 
Blank: 4 µL of 5 mM HNOCL-1 stock solution was added to 996 µL HEPES. 
 
3.4.9 Cell culture and biological studies 
Macrophages (RAW 264.7) were purchased from Sigma-Aldrich and cultured in high glucose 
Dulbecco's Modified Eagle Media (DMEM) supplemented with 10% Fetal Bovine Serum (FBS) 
and 1% antibiotics (penicillin/streptomycin, 100 U/mL). Human lung adenocarcinoma epithelial 
cells (A549) cells were purchased from ATCC and cultured in Ham’s F-12K (Kaighn’s) Medium 
supplemented with 10% Fetal Bovine Serum (FBS) and 1% antibiotics (penicillin/streptomycin, 
100 U/mL). Cells were maintained in a humidified incubator at 37 °C with 5% CO2. One or two 
days before the experiment, cells were passaged and plated on Costar® 12-well plates by adding 
150K–200K of cells per well, filling each well up to 1 mL of media. Chemiluminescent responses 
were measured using a Cytation 5 BioTek plate reader (Winooski, VT). Fluorescent imaging was 
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conducted using an EVOS-fl fluorescent microscope (Advanced Microscopy Group) equipped 
with a GFP filter cube. 
 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Human lung 
adenocarcinoma epithelial cells (A549) were purchased from ATCC and were seeded in a 96-well 
plate to a total volume of 120 μL/well. The plate was maintained at 37 °C with 5% CO2 for 12 h. 
The medium was removed upon reaching 70%–80% confluency and the cells were washed with 
PBS. The cells were incubated for 18 h after adding different concentrations of HNOCL-1 at 0, 
0.1, 1, 10, 100, and 200 μM respectively in 125 µL completed F12K media. 10 μL of the MTT 
reagent (Cayman Chemical, Ann Arbor, MI) was added to each well, and mixed gently. After 4 h 
incubation, 100 μL of crystal dissolving solution was added to each well to dissolve the formazan 
crystals. Absorbance was measured at 570 nm in a Cytation 5 BioTek plate reader and cell viability 
was expressed as a percent of the control.  
 
 
Figure 3- 18. A549 cells were incubated with 0–100 µM HNOCL-1 for 16 hours and then viability 
was evaluated using the MTT assay. Error bars are ± S.D. from n = 3 replicates. 
 
Detection of Angeli’s salt-generated HNO in living cells. Human lung adenocarcinoma 
epithelial cells (A549) or RAW 264.7 macrophages were seeded in a 12-well plate to a total 
volume of 1 mL/well. Before imaging, the medium was removed upon 90%–95% confluency and 
the cells were washed with 1 mL PBS. Each well was fill with 996 µL FluoroBrite DMEM or F-
12K media. Later, 4 µL of 5 mM HNOCL-1 in DMSO (20 µM final concentration) was added to 
each well and incubated for 30 minutes. After incubation, the medium was removed and the cells 
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(0 µL, 2.73 µL, 6.8 µL and 13.6 µL) were added to each well. The luminescence was measured 
with a Cytation 5 BioTek plate reader using the luminescence detection mode directly after the 
addition of Angeli’s Salt, end point read type. The temperature was set at 37 °C and the CO2 was 
set at 5%. Each experiment consisted of three technical replicates for each condition, and each 
experiment was repeated with three biological replicates on three separate days. The reported 
integrated chemiluminescence intensity values are the average of a total of nine wells across three 
biological replicates.  
 
Figure 3- 19. (A) Time course of chemiluminescent emission and (B) integrated emission intensity 
of RAW 264.7 macrophages incubated with 20 µM HNOCL-1 for 30 minutes, washed and then 
treated with 0, 200, 500, and 1000 µM AS. Error bars are ± S.D from n = 9 wells across 3 biological 
replicates. 
 
Detection of intracellular HNO formed from NO reduction. Human lung adenocarcinoma 
epithelial cells (A549) were seeded in a 12-well plate to a total volume of 1 mL/well. Before 
imaging, the media was removed upon 90%–95% confluency and the cells were washed with 1 
mL PBS. Each well was filled with 996 µL F-12K media. 4 µL of 5 mM HNOCL-1 stock solution 
in DMSO was added to each well (20 µM final concentration of HNOCL-1) and incubated for 30 
minutes. After incubation, the media was removed and the cells were washed with 2 x 1 mL PBS. 
An aliquot of 4 µL of 50 mM Na2S in H2O was added to the appropriate wells. Next, aliquots of 
50 mM N-acetyl-L-cysteine in H2O (2 mM final concentration) were added to the appropriate wells. 
Finally, aliquots of a 203.8 mM DEA NONOate (1 mM final concentration) were added to the 
appropriate wells. The luminescence was measured with a Cytation 5 BioTek plate reader using 
the luminescence detection mode, end point read type (Figure 3-19, A). The temperature was set 
at 37 °C under ambient atmosphere. The gain was set at 135 and the read height was set at 4.5 mm. 
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experiments are the average of 5–6 technical replicates from 2 biological replicates. Significant 
outliers (2 of 36 total data points) were excluded using a Grubb's Test for Outliers with p < 0.05.  
 
 
Fluorescence Microscopy with XF2. For cellular imaging with XF2, cells were passaged every 
3–4 days. One day before imaging, 6-well plates (Falcon) were seeded with 300,000–500,000 cells 
per well. 6-well plates were incubated in 5% CO2 and 37 ºC overnight to reach ca. 80% confluence. 
A final concentration of 10 μM XF2 was used for all experiments. Angeli’s salt was used as a 
nitroxyl donor and the stock solution concentration was determined by UV/Vis prior to use. 
Fluorescence imaging was performed in PBS or final F12K media as described above using an 
EVOS-fl inverted fluorescence microscope (Advanced Microscopy Group, Bothell, WA) equipped 
with a GFP filter cube (470/22 nm Excitation; 510/42 nm Emission) and 40x objective. Images 
were analyzed in ImageJ by converting the raw image into an 8-bit image, adjusting the threshold 
and selecting cells using the standard ImageJ Huang52 or Otsu53 algorithms, and measuring the 
mean pixel intensity in the selected areas. All quantification is from 3 fields/well with 3 biological 
replicates performed on different days (n = 9). The mean value for each set of conditions across 
all biological replicates was divided by the mean value of the controls across all biological 
replicates for normalization (n = 9). All images within each experiment were analyzed identically. 
 
Evaluation of background signal. Human lung adenocarcinoma epithelial cells (A549) were 
seeded in a 12-well plate to a total volume of 1 mL/well. Before imaging, the medium was removed 
upon 60%–80% confluency and the cells were washed with 1 mL PBS. Three wells of cells were 
treated with 4 µL of 5 mM HNOCL-1 in DMSO (20 µM final concentration) and incubated for 
30 minutes and compared to three wells of cells not treated with HNOCL-1. After incubation, the 
medium was removed and the cells were washed with 2 x 1 mL PBS. The luminescence was 
measured with a Cytation 5 BioTek plate reader using the luminescence detection mode, end point 
read type. The temperature was set at 37 °C under ambient atmosphere. The gain was set at 135 
and the read height was set at 4.5 mm. Data are from 3 technical replicates. 
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Figure 3- 20. Evaluation of background. Time-course of the chemiluminescence emission 
intensity of A549 cells incubated in the presence (red trace) or absence (blue trace) of 20 μM 
HNOCL-1. Error bars are ± S.D. from n = 3 wells of cells. 
 
Figure 3- 21. Fluorescence microscopy images of HNO detection in live A549 cells using XF2. 
A549 cells were incubated with 10 μM XF2 for 30 min in F12K media at 37 °C and washed with 
PBS before adding (A) 0 µM, (B) 50 µM, or (C) 200 µM Angeli's salt in F12K media for the final 
30 min. (D)–(E) Brightfield images of the field of cells in (A)–(C). (G) Quantification of the mean 
pixel intensity of cells of replicate experiments (n = 9; 3 biological replicates with 3 fields of cells 
in each replicate). (H) Comparison of the normalized fold turn-on of XF2 and HNOCL-1 upon 
treating cells with 200 µM Angeli's salt (dark grey bars) versus control (light grey bars). Statistical 
analysis was performed using a two-tailed Student's t-test. ** indicates a p-value < 0.001 with 


























bars for HNOCL-1 are ± S.D. from n = 9 wells across 3 biological replicates. Scale bars represent 
50 µm. 
 
Cell permeability of HNOCL-1. Human lung adenocarcinoma epithelial cells (A549) were 
seeded in a 12-well plate to a total volume of 1 mL/well. Before imaging, the medium was removed 
upon 60%–80% confluency and the cells were washed with 1 mL PBS. Each well was filled with 
996 µL F-12K media. Later, 4 µL of 5 mM HNOCL-1 in DMSO (20 µM final concentration) was 
added to three wells and incubated for 30 minutes. After incubation, the medium was removed and 
the cells were washed with 2 x 1 mL PBS. Angeli's salt (final concentration 200 µM) was added 
to the wells containing HNOCL-1 and the cells were incubated for 2 hours. Imaging was 
performed using an EVOS-fl fluorescence microscope containing a GFP filter cube (470/22 nm 
Excitation; 510/42 nm Emission), 40x objective, with the light intensity set to 70% and the 
exposure time set to 500 ms. The fluorescence emission from cells treated with probe was 
compared with the autofluorescence of untreated cells. The brightness and contrast of fluorescence 
images were identically adjusted with a minimum pixel intensity of 27 and a maximum pixel 
intensity of 91. 
 
 
Figure 3- 22. Cell permeability. Fluorescence microscopy images of (A) autofluorescence from 
untreated A549 and (B) A549 cells incubated with 20 µM HNOCL-1 for 30 minutes, washed and 
treated with 200 µM Angeli's salt. (C)–(D) Brightfield images of the fields shown in (A)–(B). 
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Imaging in Chicken Heart Tissue. Fresh chicken (gallus gallus domesticus) hearts (purchased 
from the Good Fortune Supermarket, Richardson, TX) were stored at –4 ºC. Control hearts (Figure 
3-8 A and Figure 3-12 A, top row) were injected with 20 µM HNOCL-1 in 20 mM PBS (pH 7.4) 
containing ≤ 1% DMSO and 11.7 µL 0.01 M NaOH as a vehicle control. HNO-treated hearts 
(Figure 3-8 B and Figure 3-12 A, bottom row) were injected with 20 µM HNOCL-1 in 20 mM 
PBS (pH 7.4) containing ≤ 1% DMSO and 11.7 µL of 85.5 mM Angeli's salt in 0.01 M NaOH for 
a final concentration of 1 mM Angeli's salt. Images were acquired every 30 seconds using a Caliper 
Xenogen IVIS Spectrum® (PerkinElmer, Santa Clara, CA) with a 5 second exposure time, large 
binning, f-stop set to 1, blocked excitation, open emission, FOV set to C, and height set to 1.5.  
 
 
Figure 3- 23. Imaging in heart tissue. (A) Images of chicken hearts injected with 20 µM HNOCL-
1 and (A) vehicle control or (B) 1 mM Angeli's salt in 20 mM PBS (pH 7.4) containing ≤ 1% 
DMSO (n = 3 hearts). (B) Time course of the total flux from ROIs selected around the entire hearts 
for the control experiment (blue trace) and after injection with Angeli's salt (red trace). Statistical 
analysis was performed using a two-tailed Student's t-test. For data points at time 0 and 0.5 min, p 
< 0.01 with respect to the control. For data points from 1 min to 9 min, p < 0.05 with respect to 
the control. Error bars are ± S.E. from n = 3 hearts. 
 
Imaging in Living Mice. The UT Southwestern Institutional Animal Care and Use Committee 
approved these investigations under Animal Protocol Number (APN #2017-102329). Mice were 
anesthetized and maintained using inhalation of 1.6% isoflurane. Anesthetized BALB/c nude were 






























































M NaOH) or 1 mM Angeli's salt in 20 mM PBS (pH 7.4), containing 5% DMSO. Images were 
acquired every 30 seconds using a Caliper Xenogen IVIS Spectrum® (PerkinElmer, Santa Clara, 
CA) with auto exposure, medium binning, f-stop set to 1, blocked excitation, open emission, FOV 
set to C, and height set to 1.5. Movie S1 was constructed from the frames shown in Figure 3-25 
(30 second intervals) and shows a time-lapse of the chemiluminescence imaging of the mouse 
injected with Angeli's salt. 
 
Figure 3- 24. Quantification of live animal imaging experiments. Total photon flux from nude 
BALB-C mice injected with 40 µM HNOCL-1 and vehicle control (blue trace, n = 1 mouse) or 1 




























Figure 3- 25. Frames of the Movie S1. The frames are from images collected at 30 second 
intervals for a total time-lapse of 30 minutes. 
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Synthesis of porcine liver esterase probe 
 




cyanovinyl)phenoxy)methyl 1-methylcyclopropane-1-carboxylate (19). Chloromethyl 1-
methylcyclopropanecarboxyate1 (116 mg, 0.783 mmol, 1.5 equiv) was added to the dry, N2 filled 
flask, then dissolved with 2.1 mL anhydrous acetone. NaI (129 mg, 0.858 mmol, 1.7 equiv) was 
added to the solvent and the mixture was stirred for 24 hours at ambient temperature. The reaction 
was concentrated under reduced pressure. Purification by chromatography (CH2Cl2) yielded a pale 
 
(1)  Tian, L., Yang, Y., Wysocki, L. M., Arnold, A. C., Hu, A., Ravichandran, B., Sternson, S. 












hydroxyphenyl)acrylonitrile 2 ,3  (184 mg, 0.518 mmol, 1.0 equiv) was dissolved with 2.0 mL 
anhydrous DMF in an dry, N2 filled flask and anhydrous N,N-diisopropylethylamine (DIPEA, 0.19 
mL, 1.1 mmol, 2.1 equiv) was added to the solvent. The pale yellow oil was dissolved with 3.0 
mL anhydrous DMF and added to the flask. The reaction mixture was stirred for 21 h at ambient 
temperature. The reaction was concentrated under reduced pressure. Purification by column 
chromatography (1:20 EtOAc/Hexane) yielded 19 as a white solid (107 mg, 44%). 1H NMR (500 
MHz, CDCl3) d 7.63 (d, 1H, J = 16.6 Hz), 7.36 (d, 1H, J = 8.1 Hz), 7.11 (d, 1H, J = 8.1 Hz), 5.95 
(d, 1H, J = 16.6 Hz), 5.70 (m, 2H), 3.29 (s, 1H), 3.25 (s, 1H), 2.04 (s, 1H), 1.94–1.63 (m, 12H), 
1.28 (s, 3H), 1.23 (m, 2H), 0.77 (m, 2H); 13C NMR(500 MHz, CDCl3) d 175.07, 152.02, 144.76, 
139.33, 139.04, 133.30, 129.21, 128.62, 128.54, 123.91, 117.83, 98.59, 89.32, 57.44, 39.19, 39.03, 
38.61, 38.56, 36.96, 32.91, 31.59, 29.73, 28.29, 28.11, 19.10, 18.54, 17.60; HRMS calcd for 





4'-yl)phenoxy)methyl 1-methylcyclopropane-1-carboxylate (Chemilum-CM2). Enol ether 19 
(107 mg, 0.230 mmol, 1.0 equiv) was dissolved with 5 mL THF at 0 °C in a two-neck flask and 
rose bengal (12.4 mg, 0.0122 mmol, 0.050 equiv) was added to the solvent. O2 was bubbled 
through the solvent when illuminated with a 120W light bulb (Home Depot, Dallas, TX). The 
reaction was monitored by TLC. After 3 h 15 min, the mixture was concentrated under reduced 
pressure. Purification by column chromatography (1:20 EtOAc/Hexane) and yield Chemilum-
CM2 as a white solid (76.9 mg, 67%). 1H NMR (500 MHz, CDCl3) d 7.97 (d, 1H, J = 8.6 Hz), 
7.66 (d, 1H, J = 16.7 Hz), 7.52 (d, 1H, J = 8.6 Hz), 6.03 (d, 1H, J = 17.2 Hz), 5.67 (dd, 2H), 3.21(s, 
 
(2)  Cao, J., An, W. W., Reeves, A. G., Lippert, A. R. Chem. Sci., 2018, 9, 2552–2558. 










3H), 3.01(s, 1H), 1.96 (s, 1H), 1.85-1.58(m, 12H), 1.28 (s, 3H), 1.23 (m, 2H), 0.79 (m, 2H); 13C 
NMR(500 MHz, CDCl3) d 175.11, 152.70, 144.42, 136.53, 130.51, 129.80, 127.19, 124.13, 117.63, 
111.63, 99.99, 96.48, 89.32, 49.87, 36.57, 33.99, 33.66, 32.67, 32.24, 31.62, 31.58, 29.82, 26.17, 





























Cell Culture Protocol 
 
Media/reagent for cell lines: 
Currently, the cell lines being used in the lab are A549 lung cancer epithelium and RAW 264.7 
macrophage cells.  
For A549: Complete F12K medium is typically used.  
For Macrophages: Complete DMEM medium is used. 
 
Preparation of complete medium: 10% FBS and 1% antibiotic in completed media. 
Under the hood, open a new 500 mL bottle of the media. Using a 55 mL pipette, remove 55 mL of 
media into a falcon tube and keep aside. Add 50 mL FBS (filtered if possible, but not totally 
necessary) and 5 mL of pen/strep antibiotic to the 455 mL medium. Pipette up and down. Label as 
Opened and complete, with date and initials and store in the refrigerator. FBS is stored in the -80 
ºC freezer (prepare 4 aliquots of 50 mL in each Falcon tube before storing). 
 
Thawing of vials and seeding:  
1. New vials of cells can be ordered through the ATCC website, paying careful attention to 
cell line/strain description. 
2. If thawing a vial that is stored in our liquid nitrogen dewar, keep track of vials used. Make 
sure to label the removed cells on the Liquid Nitrogen Storage Chart. 
3. Thawing: Keep the appropriate media warmed in the water bath to 37 ºC and sterilize the 
hood with UV light for at least 10 mins. With a pipette, pour about 10 mL of warmed 
completed media into a 15 mL or 50 mL falcon tube. The vial of cells is carefully dipped 
(not immersed) in water bath until just a tiny portion of the ice is remaining. Remove the 
vial and wipe with ethanol.  
4. Open lid of vial slowly to release pressure and then transfer the contents into the media of 
the falcon tube with the 1000 µL pipet. 
5. Centrifuge for 10 minutes at 1000 rpm. 
6. With a pipette, pour 20 mL of warmed completed media into a T75 flask (or 3 mL to a T25 
flask). Taking the falcon tube out, aspirate liquid supernatant and disperse the pellet in 
around 1 mL of fresh completed media. Add all the cells to the T75 flask and distribute 
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cells with gently rocking of the flask. Label the flask with date, passage number, cell line 
and initials and place in the incubator.  
7. On the next day, check the cells and remove the media with the aspirator. Add 20 mL new 
complete media to the T75 flask. The purpose of this step is to remove the dead cells that 




1. Keep the F12K complete media, PBS and 0.25 % trypsin in the water bath about 30 mins 
to warm up to 37 ºC. Turn on the UV of the hood and leave between 10 – 30 mins. 
2. When the bottles are warm, wipe out the water, spray with alcohol and keep ready in the 
hood, remove the flask from the incubator and aspirate the media. Wash the cells once with 
about 10 mL PBS. Aspirate the PBS. 
3. Add around 2 mL of trypsin to the T75 flask (1 mL for T25). Move the plate around a bit 
to make sure all the cells are coated with trypsin. Keep the flask in the incubator for 8 to 
10 mins. Trypsin breaks the bonding between the cell surface and the bottom of the flask 
so that cells will detach and float.  
4. Add between 10 mL of media to the flask and then transfer all the contents to a falcon tube. 
Centrifuge 10 mins at 1000 rpm. 
5. Aspirate the supernatant. Thoroughly distribute the cells in around 1 mL of media with up 
and down motions of the pipette. 
6. In a T75, pipette in about 20 mL of completed F12K. Depending on how many cells you 
need, transfer about 150 µL of the cell cocktail to the flask. Distribute thoroughly with 
gentle rocking of the flask. Label with date, passage number and generation, date and your 
initial and put back to the incubator. 
 
Macrophage: 
1. Keep the DMEM complete media, PBS and 0.25 % trypsin in the water bath about 30 mins 
to warm up to 37 ºC. Turn on the UV of the hood and leave between 10 – 30 mins. 
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2. When the bottles are warm, wipe out the water, spray with alcohol and keep ready in the 
hood, along with a cell scraper, remove the flask from the incubator and aspirate the media. 
The cells are washed once with about 10 mL PBS. Aspirate the PBS. 
3. Add around 1 mL of 0.25 % trypsin to the T25 flask (The amount of trypsin is depending 
on the size of the T flask). Using the cell scraper, gently but quickly scrape all the cells off 
the bottom of the flask. Do not allow the cells to be exposed too long to trypsin, since cells 
become sticky. 
4. Add between 10 mL of completed DMEM media to the flask and then transfer all of the 
contents to a falcon tube. Centrifuge 10 mins at 1000 rpm. 
5. Aspirate the supernatant. Thoroughly distribute the cells in around 1 mL of completed 
DMEM media with up and down motions of the pipette. 
6. In a T75, pipette in 20 mL of DMEM. Then depending on how many cells you need, 
transfer about 150 µL of the cell cocktail to the flask. Label with date, passage number and 




1. Freezing of cells should be done after about 2 to 3 passages from a fresh thawed vial. Do 
not allow for more passages to be done before freezing a batch of cells. It is recommended 
that after thawing of a vial, the cells need to grow enough to make enough vials.  
2. Make sure cell confluency is around 80–90% but not overgrown. 
3. Cell freezing media needs to be prepared ahead of time. It is 10% cell-culture grade DMSO 
in complete media.  
4. Warm complete media, PBS, trypsin and cell freezing media and make sure hood has been 
UV treated. Follow all the passaging steps for your cells line up to the pellet formation. 
5. Aspirate the media and keep the pellet. From a sufficiently confluent flask you can make 
around 10 vials of cells. Prepare 10 mL cell freezing media. Add 1 mL of cell freezing 
media to the pellet first to disperse the cells thoroughly. Later add the rest of the freezing 
media to the falcon tube. It is better to add 1ml first, then add the rest and mix. 
6. The cryopreservation vials are used to freeze cells. Add 1 mL of the cell cocktail into as 
many vials as possible with pipet. Close the vials tightly, label them with cell type, 
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generation and passage number, date and initials. Parafilm the lids of all the vials. Store 
them in a Mr. Frosty freezing container containing ethanol and keep overnight in the –80 
ºC freezer (Dr. Zoltowski’s lab). Three days later, transfer the vials to the liquid nitrogen 
dewar, make a note of the date stored, location and number of vials on the Liquid Nitrogen 
Storage Chart. 
 
Incubator and water bath water maintenance (Monthly) 
 The incubator needs to be at 37 ºC, 5% CO2 and water filled on the bottom to maintain 
humidity and temperature. The water to needs be autoclaved before filling and treated with a 
disinfectant (aquaguard from Sigma or Conflikt from VWR) about once a month. 2% of 
disinfectant in autoclaved water should be enough. Conflikt is also used to wipe down the incubator 
every semester on group clean-up day (instead of alcohol). The water in the water bath needs to 
be changed and treated in the same way (once a semester on group clean-up day). 
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SCANNED 1H NMR AND 13C NMR SPECTRA 
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